EP3377000B1 - Dispositif implantable et système de mise en place pour remodeler un anneau de valve cardiaque - Google Patents

Dispositif implantable et système de mise en place pour remodeler un anneau de valve cardiaque Download PDF

Info

Publication number
EP3377000B1
EP3377000B1 EP16804980.7A EP16804980A EP3377000B1 EP 3377000 B1 EP3377000 B1 EP 3377000B1 EP 16804980 A EP16804980 A EP 16804980A EP 3377000 B1 EP3377000 B1 EP 3377000B1
Authority
EP
European Patent Office
Prior art keywords
implant
frame
crowns
collars
struts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP16804980.7A
Other languages
German (de)
English (en)
Other versions
EP3377000A1 (fr
Inventor
Randall Lashinski
Kristian KRISTOFFERSEN
Matthew Rust
Richard Glenn
Terry Wayne DANIELS
Michael Lee
Patrick Macaulay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Scimed Inc
Original Assignee
Boston Scientific Scimed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Scientific Scimed Inc filed Critical Boston Scientific Scimed Inc
Publication of EP3377000A1 publication Critical patent/EP3377000A1/fr
Application granted granted Critical
Publication of EP3377000B1 publication Critical patent/EP3377000B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2445—Annuloplasty rings in direct contact with the valve annulus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/064—Surgical staples, i.e. penetrating the tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418—Scaffolds therefor, e.g. support stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427—Devices for manipulating or deploying heart valves during implantation
    • A61F2/2436—Deployment by retracting a sheath
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427—Devices for manipulating or deploying heart valves during implantation
    • A61F2/2439—Expansion controlled by filaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2466—Delivery devices therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/064—Surgical staples, i.e. penetrating the tissue
    • A61B2017/0647—Surgical staples, i.e. penetrating the tissue having one single leg, e.g. tacks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/064—Surgical staples, i.e. penetrating the tissue
    • A61B2017/0649—Coils or spirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008—Fixation appliances for connecting prostheses to the body
    • A61F2220/0016—Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0004—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
    • A61F2250/001—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable for adjusting a diameter

Definitions

  • implantable medical devices In general, features related to implantable medical devices are described. For example, heart valve medical devices and delivery and positioning systems for implanting various devices are described.
  • Heart valve incompetency is a serious problem.
  • heart disease can cause the chambers of the heart to expand and weaken.
  • the left ventricle dilates and the papillary muscles are displaced. Consequently, the annulus of the mitral heart valve dilates excessively.
  • valve leaflets no longer effectively close, or coapt, during systolic contraction. Consequently, regurgitation (i.e. retrograde flow back across the valve that should be closed) of blood occurs during ventricular contraction. Cardiac output is thus decreased.
  • This procedure is invasive as it is performed open chest and is also time consuming.
  • open heart surgery the patient is put on cardiopulmonary bypass with its associated risks of morbidity and mortality due to stroke, thrombosis, heart attack and extended recovery time.
  • US 9,180,005 B1 discloses an adjustable endoluminal mitral valve ring.
  • the present invention is directed to an implant for reducing heart valve regurgitation a set forth in the claims.
  • the implant for reducing heart valve regurgitation comprises a frame having upper crowns, lower crowns and struts between the upper and lower crowns, the frame having a tissue engaging configuration having a tissue engaging diameter and an annulus remodeling configuration where the frame has an annulus remodeling diameter that is less than the tissue engaging diameter.
  • the implant further comprises a plurality of anchoring members coupled with the lower crowns of the frame for engaging cardiac tissue proximate the heart valve annulus; and a plurality of collars coupled with the upper crowns of the frame, wherein when force is applied to the collars, the collars slide along the upper crowns and the struts to move the frame from the tissue engaging configuration towards the annulus remodeling configuration.
  • the lower crowns are inclined at an angle with respect to the struts.
  • the implant is intended to be delivered in a minimally invasive percutaneous manner, such as transfemorally, transeptally, or transapically.
  • the implant may instead be implanted surgically, in that it should reduce the duration of the procedure and, more particularly, the duration that the patient is on bypass.
  • the development can be directed to mitral valve or tricuspid valve procedures.
  • the development relates to the implant and delivery systems, and associated methods of use of each.
  • the implant contracts to a first configuration, such as a delivery configuration, having a first diameter for delivery via a delivery catheter.
  • the implant is capable of expanding out to a second configuration, such as a tissue engaging configuration (and/or anchored configuration), having a second diameter larger than the first diameter to match the width of a dilated annulus of a heart valve.
  • the implant engages the tissue of the heart valve annulus and then contracts to a third configuration, such as an annulus remodeling diameter, having a third diameter that is smaller than the second diameter, thus gathering and cinching in the dilated annulus to decrease the width of the dilated annulus.
  • the implant includes a tubular frame with moveable struts, where pairs of adjacent struts form apices.
  • the apices have collars at least partially surrounding the apex.
  • the collars can be moved along the apex, e.g. downward or upward along the apex, to decrease the angle between the adjacent struts, causing the tubular frame to contract in width. This pulls the tissue of the heart valve annulus closer together.
  • the implant thus reconfigures the valve annulus down to a smaller diameter, reducing and/or eliminating problems associate with the valve, such as regurgitation.
  • a delivery system and associated methods are also disclosed that comprise a catheter and imaging and positioning features to maneuver the distal end of the catheter and the device into the desired position above and proximate the heart valve annulus.
  • Transeptal delivery may be used, for example, with procedures involving the mitral valve.
  • the delivery system can be used with the implant described herein as well as other implantable devices.
  • the development also provides an artificial heart valve with a modified ring-like structure that not only provides for reduction of the heart valve annulus, but also displaces or replaces one or more defective heart valve leaflets.
  • the artificial valve may include the various implant devices described herein having the one or more leaflets attached thereto.
  • an implant for reducing heart valve regurgitation comprises a frame, a plurality of anchoring members and a plurality of collars.
  • the frame has upper crowns, lower crowns and struts between the upper and lower crowns.
  • the frame has a tissue engaging configuration having a tissue engaging diameter, and an annulus remodeling configuration where the frame has an annulus remodeling diameter that is less than the tissue engaging diameter.
  • the plurality of anchoring members are coupled with the lower crowns of the frame for engaging cardiac tissue proximate the heart valve annulus.
  • the plurality of collars are coupled with the upper crowns of the frame, wherein when force is applied to the collars, the collars slide along the upper crowns and the struts to move the frame from the tissue engaging configuration towards the annulus remodeling configuration.
  • the plurality of anchoring members are helically wound anchoring members and the lower crowns of the frame are adapted to threadingly receive the helically wound anchoring members.
  • the helically wound anchoring members may further include anchoring heads for engagement with actuators to rotationally advance the helically wound anchoring members in the cardiac tissue to anchor the frame into the cardiac tissue.
  • the implant may further comprise abutments on each of the anchor heads to engage with the struts and the lower crowns to limit travel of the helically wound anchoring members.
  • the helically wound anchoring members may have sharpened tips to facilitate penetration of the helically wound anchor members into the cardiac tissue.
  • the implant may further comprise at least one tab on each of the collars, with the tabs inwardly biased to engage with the upper crowns when the collars are slid over the upper crowns and struts.
  • the implant may further comprise a groove formed on an outwardly facing side of the upper crowns and at least one tab on each of the collars with the tabs inwardly biased to engage with the groove.
  • Each of the collars may comprise a plurality of the tabs, and the plurality of tabs can be advanced over the upper crowns and struts to selectively vary the annulus remodeling diameter of the frame.
  • the plurality of tabs may be vertically disposed on an outwardly facing portion of the collars and comprise a lowermost tab, with the lowermost tab initially disposed and engaged with an underside of the upper crown.
  • the implant may further comprise a plurality of pusher members that engage with the plurality of collars to forcibly advance the collars over the upper crowns and struts to reduce the diameter of the frame.
  • the implant may further comprise flex sections on the collars to facilitate advancement of the collars over the upper crowns and struts.
  • the frame may define a longitudinal axis, and the lower crowns and anchoring members received in the lower crowns may be inclined outwardly in a distal direction at an angle between about 30° to about 60° with respect to a portion of the axis that extends distally below the implant.
  • a delivery system for delivering an implant for reducing heart valve regurgitation comprises the implant, a delivery catheter, and an imaging catheter.
  • the implant comprises a frame, a plurality of anchoring members and a plurality of collars.
  • the frame has upper crowns, lower crowns and struts between the upper and lower crowns, and a tissue engaging configuration with a tissue engaging diameter and an annulus remodeling configuration where the frame has an annulus remodeling diameter less than the tissue engaging diameter.
  • the plurality of anchoring members are coupled with the lower crowns of the frame for engaging cardiac tissue proximate the heart valve annulus.
  • the plurality of collars are coupled with the upper crowns of the frame, and when force is applied to the collars, the collars slide on the upper crowns and the struts to move the frame from the tissue engaging configuration towards the annulus remodeling configuration.
  • the delivery catheter is releasably attached to the implant and is configured to deliver the implant to a position proximate the heart valve annulus.
  • the imaging catheter comprises a distal end configured to extend proximate the heart valve annulus and to capture one or more images therein of the position of the implant relative to the heart valve annulus.
  • the delivery system further comprises a plurality of actuating members for engaging corresponding anchoring members of the implant to cause the anchoring members to penetrate and advance into the cardiac tissue to anchor the frame in position proximate the heart valve annulus.
  • the delivery system may further comprise a plurality of pusher members for engaging corresponding collars of the implant to forcibly advance each collar over its respective upper crown and struts thereby reducing the diameter of the frame and the valve annulus.
  • the delivery system may further comprise means for centering the imaging catheter with respect to the implant.
  • the distal end of the imaging catheter may comprise longitudinally disposed and circumferentially disposed ultrasound transducers.
  • the frame may define a longitudinal axis, and the lower crowns and anchoring members received in the lower crowns may be inclined outwardly in a distal direction at an angle of approximately 45° with respect to a portion of the axis that extends distally below the implant.
  • the delivery system may further comprise a loop encircling the frame proximate its lower crowns, and a constricting actuator to constrict the loop to facilitate collapse and loading of the implant into the delivery system.
  • Each of the collars may comprise a plurality of tabs that are inwardly biased to engage with corresponding undersides of the upper crowns when the collars are slid over the upper crowns and struts by the pusher members. After the frame has been anchored into the cardiac tissue, the loop may be constricted to determine the desired reduction in diameter of the frame prior to advancing the collars and tabs over the respective upper crowns and struts.
  • a method of reducing the size of an enlarged heart valve annulus comprises the steps of delivering an implant in a delivery system to a site above and proximate the enlarged heart valve annulus, the implant having a proximal end and a distal end; releasing the implant from the delivery system to allow the implant to take on a tissue engaging diameter; anchoring the distal end of the implant into cardiac tissue proximate and above the enlarged heart valve annulus; translating a plurality of collars over corresponding upper crowns of the proximal end of the implant to reduce the tissue engaging diameter to an annulus remodeling diameter, thereby reducing the size of the enlarged heart valve annulus; and disengaging the anchored and reduced diameter implant from the delivery system.
  • a heart valve replacement implant comprises a replacement valve, a tubular valve housing, a cinch frame, a plurality of anchoring members and a plurality of collars.
  • the replacement valve has a plurality of replacement valve leaflets.
  • the tubular valve housing is fixedly attached to the replacement valve leaflets.
  • the cinch frame is connected to and circumferentially surrounds the tubular valve housing.
  • the cinch frame has upper crowns, lower crowns and struts between the upper and lower crowns, and is configurable between a tissue engaging configuration with opposing upper crowns separated by a tissue engaging diameter and an annulus remodeling configuration with opposing upper crowns separated by an annulus remodeling diameter that is less than the tissue engaging diameter.
  • the plurality of anchoring members are coupled with the upper crowns of the cinch frame for engaging cardiac tissue proximate the heart valve annulus.
  • the plurality of collars are coupled with the lower crowns of the cinch frame. When force is applied to the collars, the collars slide on the lower crowns and the struts to reconfigure the cinch frame from the tissue engaging configuration towards the annulus remodeling configuration.
  • the heart valve replacement implant further comprises a sealing flange on the cinch frame that is disposed on the atrial side of the heart valve when the heart valve replacement system is implanted.
  • a heart valve replacement implant comprises a replacement valve, a tubular valve, a cinch frame, a plurality of anchoring members and a plurality of collars.
  • the replacement valve has a plurality of replacement valve leaflets.
  • the tubular valve housing is fixedly attached to the replacement valve leaflets.
  • the cinch frame is connected to and circumferentially surrounds the tubular valve housing.
  • the cinch frame has upper crowns, lower crowns and struts between the upper and lower crowns, and is configurable between a tissue engaging configuration with opposing lower crowns separated by a tissue engaging diameter and an annulus remodeling configuration with opposing lower crowns separated by an annulus remodeling diameter that is less than the tissue engaging diameter.
  • the plurality of anchoring members are coupled with the lower crowns of the cinch frame for engaging cardiac tissue proximate the heart valve annulus.
  • the plurality of collars are coupled with the upper crowns of the cinch frame. When force is applied to the collars, the collars slide on the upper crowns and the struts to reconfigure the cinch frame from the tissue engaging configuration towards the annulus remodeling configuration.
  • the tubular valve housing has a proximal end and a distal end
  • the upper crowns of the cinch frame have extensions adapted to be received in openings in the proximal end of the valve housing such that the upper crowns and the cinch frame pivot about the proximal end of the valve housing.
  • the present invention is directed to an implant for reducing heart vlave regurgitation as set forth in the appended claims.
  • the following detailed description is directed to certain specific embodiments of the development.
  • Reference in this specification to "one embodiment,” “an embodiment,” or “in some embodiments” means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment of the invention.
  • the appearances of the phrases “one embodiment,” “an embodiment,” or “in some embodiments” in various places in the specification are not necessarily all referring to the same embodiment, nor are separate or alternative embodiments necessarily mutually exclusive of other embodiments.
  • various features are described which may be exhibited by some embodiments and not by others.
  • various requirements are described which may be requirements for some embodiments but may not be requirements for other embodiments.
  • FIGS. 1 through 4 are perspective views of an embodiment of an implant 1.
  • the implant 1 is intended to be delivered proximate to, above and/or or within, the cardiac valve annulus.
  • valve as used herein may refer to any of a variety of valves, including the tricuspid or mitral valve of the heart.
  • the implant 1 may be subsequently implanted in the annular cardiac tissue just above the plane of the valve orifice.
  • the implant may be a heart valve replacement including valve leaflets, which can be implanted in annular cardiac tissue and extend into the valve annulus, as further described herein.
  • implant, delivery system, and related systems and methods of use of the implant and delivery system are described herein.
  • the implant, delivery system, and related systems and methods of use may have the same or similar features and/or functionalities as other implants, delivery systems, and related systems and methods of use as described, for example, in U.S. Patent Application 14/861,877 entitled "ADJUSTABLE ENDOLUMENAL IMPLANT FOR RESHAPING MITRAL VALVE ANNULUS and filed on September 22, 2015 , as described, for example, in U.S. Provisional Application No.
  • the implant 1 is an implantable device.
  • the implant 1 forms an opening 3 extending through the implant 1.
  • a geometric reference longitudinal axis is indicated.
  • the implant 1 may be described with reference to the axis.
  • An “axial” direction refers to movement generally parallel to the axis in either an upward or downward direction, unless otherwise indicated.
  • the opening 3 extends axially between an upper portion 2 of the implant 1 and a lower portion 4 of the implant 1.
  • the upper and lower portions 2, 4 may include various features of the implant 1.
  • the terms “upper,” “upward,” and the like refer to directions generally toward the upper portion 2, and the terms “lower,” “downward,” and the like refer to directions generally toward the lower portion 4, unless otherwise indicated.
  • Proximal refers to a direction in the upward direction
  • distal refers to a direction in the downward direction.
  • inner refers to directions generally toward the axis
  • outer refers to directions generally away from the axis, unless otherwise indicated.
  • the implant 1 includes a frame 10.
  • the frame 10 extends around and partially along the axis.
  • the axis may be defined by the frame 10.
  • the frame 10 is generally symmetric with respect to the axis. However, the frame 10 need not be symmetric with respect to the axis.
  • the frame 10 has a generally tubular shape. "Tubular” includes circular as well as other rounded or otherwise closed shapes.
  • the frame 10 is generally circular about the axis.
  • the frame 10 may be circular, rounded, ellipsoidal, segmented, other shapes, or combinations thereof.
  • the frame 10 may change shape, size, configuration, etc.
  • the frame 10 may have various shapes, sizes, configurations etc. at various phases of use, e.g. pre-delivery, during delivery, after engagement with tissue, after contracting the annulus, post-contraction, during the lifetime of use while implanted, etc.
  • the implant 1 includes one or more struts 12.
  • the struts 12 are part of the frame 10.
  • the struts 12 are elongated structural members.
  • the struts 12 and/or other parts of the frame 10 are formed of a metal alloy.
  • the struts 12 and/or other parts of the frame 10 may be formed of an alloy of nickel titanium.
  • the struts 12 and/or other parts of the frame 10 are formed of other metals, metal alloys, plastics, polymers, composites, other suitable materials, or combinations thereof.
  • the struts 12 may be part of the same, monolithic piece of material (e.g. tube stock). Thus the struts 12 may refer to different portions of the same, extensive component.
  • the struts 12 may be formed from the same piece of material.
  • the struts 12 may be formed separately and attached permanently together, e.g. by welding, etc.
  • the struts 12 may be separate components that are detachably coupled together by other components of the implant 1.
  • the struts 12 may be held together via various components described herein, such as collars 18, anchors 20, other features, or combinations thereof.
  • separate strut units may include two or more struts permanently attached together such as at an apex, and the separate units may each be coupled together, either permanently or detachably, to form the frame 10.
  • the struts 12 may be attached by hinges, pins, or other suitable means.
  • the elongated, middle portions of the struts 12 have a generally rectangular cross-section but can vary in circumferential width and radial thickness to allow for different beam characteristics and forces applied as the collars are advanced.
  • the long ends of the rectangular cross-section of the struts 12 extend along the circumference of the frame 10.
  • "Circumference" as used herein generally refers to a perimeter or boundary and can refer to a circular or other rounded or non-rounded path lying in a plane substantially transverse to the axis, unless otherwise stated.
  • the short ends of the rectangular cross-section of the struts 12 extend transversely to the circumference of the frame 10. In some embodiments, other configurations and/or cross-sectional shapes of the struts 12 may be implemented.
  • the struts 12 extend around the axis to form the various shapes of the frame 10.
  • the struts 12 are arranged such that the wall pattern of the frame 10 may be approximately sinusoidally or zig-zag shaped. In some embodiments, the wall pattern may have other suitable shapes, sinusoidal or otherwise.
  • the vertices of the sinusoidal shaped frame 10 may be pointed or rounded.
  • Pairs of adjacent struts 12 meet at an apex. At least a first pair of adjacent struts 12 meets at an upper apex or crown 14 at the upper portion 2 of the implant 1. At least a second pair of adjacent struts 12 meets at a lower apex or crown 16 at the lower portion 4 of the implant 1.
  • the terms "apex,” apices,” and the like may be used interchangeably with terms “crown,” “crowns,” and the like, as used herein, unless otherwise stated.
  • the upper and lower crowns 14, 16 are spaced sequentially along the circumference of the frame 10, with one of the upper crowns 14 followed by one of the lower crowns 16, followed by another one of the upper crowns 14, etc.
  • the upper crowns 14 are each configured to have a restraint such as a collar 18 fitted over and/or around the upper crown 14.
  • the upper crowns 14 may include various features, dimensions, etc. as described herein for coupling with the collar 18, as further described.
  • the upper crowns 14 are shown partially covered by the collars 18 in FIG. 1 .
  • the upper ends of the upper crowns 14 are more clearly seen in FIG. 4 , where the collars 18 have been moved distally toward the lower portion 4 of the implant 1 relative to their position in FIG. 1 .
  • one or more of the upper crowns 14 may not have the collar 18.
  • fewer than all of the upper crowns 14 are configured to receive the collar 18.
  • all of the upper crowns 14 may be configured to receive the collar 18 but when implanted only some of the upper crowns 14 may actually include the collar 18.
  • At least two and optimally at least four or six or all of the lower crowns 16 are configured for coupling with an anchor 20.
  • the anchor 20 is moveably coupled with the lower crown 16.
  • the anchor 20 engages with tissue of the heart, for example the annulus, to secure the implant 1 to the tissue, as further described herein. Movement of the anchor 20 relative to the lower crowns 16 causes the anchor 20 to penetrate the tissue.
  • the lower crowns 16 may include a variety of engagement features to allow such movement of the anchors 20, such as flanges and/or the openings 17.
  • the lower crowns 16 each include a series of the openings 17 extending through the lower crowns 16. The openings 17 extend in two spaced columns in the axial direction along the lower crown 16.
  • the openings 17 in each column are alternately located in the axial direction, as shown, to accommodate receipt of the anchor 20 therein. Other configurations and/or spacings of the openings 17 may be implemented. For clarity, only some of the openings 17 are labeled in FIG. 1 .
  • the openings 17 are shown as circular holes. Other shaped openings 17 may be implemented.
  • the openings 17 of the lower crown 16 are configured to rotatably receive a helical segment of the corresponding anchor 20 such that the anchor extends sequentially through the openings 17, both while the anchor 20 moves relative to the struts 12 and while the anchor 20 is stationary relative to the struts 12, as further described herein.
  • features alternative to or in addition to the openings 17 may be used to couple the anchor 20 with the corresponding lower crown 16.
  • fewer than all of the lower crowns 16 may be configured for coupling with the anchor 20. Thus one or more of the lower crowns 16 may not have the openings 17 and/or other features for coupling with the anchor 20.
  • all of the lower crowns 16 may be configured for coupling with the anchor 20, but when implanted only some of the lower crowns 16 may actually include the anchor 20.
  • the struts 12 are reconfigurable about the upper and lower crowns 14, 16. Pairs of adjacent struts 12 that meet at the upper and lower crowns 14, 16 can move angularly relative to each other. Such movement may be described as a rotation or pivot of the adjacent struts 12 about the corresponding upper or lower crown 14, 16. For example, two adjacent struts 12 forming the upper crown 14 may be moved such that the struts 12 effectively rotate relative to each other about the upper crown 14. For example, two adjacent struts 12 forming the lower crown 16 may be moved such that the struts 12 effectively rotate relative to each other about the lower crown 16. "Rotation" of the struts 12 as described includes pinching together of the struts 12, for example with the collar 18 as described herein.
  • adjacent struts 12 may not include an actual rotatable hinge, pin, or other rotation features. Movement of the struts 12 closer together to decrease the angle therebetween is described as a "closing" of the struts 12. Movement of the struts 12 farther apart to increase the angle therebetween is described as an "opening" of the struts 12.
  • the struts 12 may be biased to an enlarged cross-sectional configuration in the absence of an external force applied to the struts 12.
  • Application of an external circumferentially compressive force to the struts 12, for example with the collar 18, causes the struts 12 to move angularly, for example to close. Movement of the struts 12 in this closing manner also causes the implant 1 to decrease its circumference( e.g. diameter) in the case of a circular implant 1.
  • the frame 10 In its free, unconstrained state, the frame 10 may be in an enlarged configuration.
  • Application of the compressive circumferential force causes the circumference of the frame 10 to reduce. Removal or lessening of the circumferential force allows the frame 10 to open.
  • the circumferential force may be increased or decreased by moving the collar 18 farther downward or upward, respectively, in the axial direction, as further described herein.
  • the collar 18 may lock in place after translating axially down the upper crown 14 to secure the implant 1 at a particular width.
  • the implant 1 includes one or more restraints such as the sliders or collars 18.
  • the terms “collar,” collars,” and the like may be used interchangeably with the terms “slider,” “sliders,” “sliding members,” and the like, unless otherwise stated.
  • the implant 1 includes eight collars 18. In some embodiments, there may be fewer or more than eight collars 18.
  • the number of collars 18 may correspond to the number of upper crowns 14. In some embodiments, there may be fewer collars 18 than upper crowns 14. Thus, in some embodiments, some upper crowns 14 of the frame 10 may not include the collar 18.
  • the collar 18 couples with the corresponding upper crown 14.
  • the collar 18 may be fitted over the upper crown 14.
  • the collar 18 forms an inner opening at least partially therethrough and into which the upper crown 14 is received as the collar 18 fits over the upper crown 14.
  • the collar 18 may have a rectangular profile as shown.
  • the collar 18 may have other profiles, e.g. rounded, segmented, polygonal, other suitable shapes, or combinations thereof.
  • the profile of the collar 18 may be a closed shape, as shown, or it may be an open shape such as a "C" shape.
  • the collar 18 thus at least partially surrounds the corresponding upper crown 14. As shown, the collar 18 completely surrounds the corresponding upper crown 14. In some embodiments the collar 18 may not completely surround the upper crown 14.
  • the collar 18 engages with the upper crown 14.
  • the collar 18 may engage with circumferentially opposed sides of the upper crown 14 and/or adjacent struts 12.
  • the collar 18 engages with and may be advanced downward over the upper crown 14 to angularly move the corresponding pair of adjacent struts 12 towards each other.
  • the collar 18 may apply a compressive circumferential force to the struts 12 to cause the struts 12 to decrease the angle between the struts 12.
  • the circumferential force may be applied inwardly to the struts 12 and towards the upper crown 14.
  • a vertical force applied to the collars 18 may be translated into a circumferential force on the struts 12.
  • circumferential it is meant that the direction of the forces is along the outer perimeter or boundary of the frame 10 as viewed from the top or bottom of the frame 10, and is not meant to limit the shape of the frame 10 to a circle. Movement of the collar 18 over the struts 12 moves, e.g. rotates, the struts 12 such that the angle between the adjacent struts 12 decreases. A first circumferential force may be applied to one of the struts 12 by the collar 18 and a second circumferential force that is opposite in direction to the first circumferential force may be applied to the adjacent strut 12 by that same collar 18.
  • the struts 12 thus move relative to each other about the upper crown 14 due to movement of the collar 18.
  • the collar 18 may lock in place, for example with a locking tab 19.
  • the collar 18 may include the locking tab 19.
  • the locking tab 19 provides an engagement feature for the collar 18 to engage with the struts 12.
  • the locking tab 19 locks the collar 18 in place on the upper crown 14 after movement of the collar 18 over the upper crown 14.
  • the locking tab 19 is biased toward the inner opening formed by the collar 18.
  • the locking tab 19 may be shape set to take on an inwardly oriented bias.
  • the collar 18 and/or features thereof such as the locking tab 19 are formed of a nickel titanium alloy such as Nitinol.
  • the collar 18 and/or features thereof such as the locking tab 19 are formed of other materials, such as metals, other metal alloys, plastics, polymers, composites, other suitable materials, or combinations thereof. Further details of various embodiments of the collar 18, and features thereof such as the locking tab 19, are described herein.
  • the collars 18 may thus provide one or more functions for the implant 1.
  • the collars 18 may cinch the frame 10, as described.
  • the frame 10 may be cinched by features in addition to or alternatively to the collars 18, and the collars 18 may restrain the frame 10 in the cinched state.
  • the collars 18 may thus not cinch the frame 10 but only restrain the frame 10 in the cinched state.
  • the collars 18 may cinch the frame 10 as well as restrain the frame 10 in the cinched state.
  • the implant 1 includes one or more anchors 20.
  • the anchors 20 have anchor heads 22 attached at their upper or proximal ends.
  • each anchor head 22 comprises an abutment 24 and an engagement structure such as a hook 26.
  • the abutment 24 may be a cap portion on an upper end of the anchor 20.
  • the abutment may be cylindrical.
  • the abutment 24 may have a width sized to limit axial advance of the anchor 20, as described herein.
  • the hooks 26 are elongated, over-hanging members.
  • the hooks 26 may provide an engagement for a delivery tool.
  • the hooks 26 may interact with a delivery tool to rotate and axially advance the anchors 20, as described herein.
  • features other than the hooks 26 may be used, for example eye bolts.
  • the anchors 20 are made of a suitable biocompatible metal alloy such as stainless steel, cobalt chromium, platinum iridium, nickel titanium, other suitable materials, or combinations thereof. Each anchor 20 is sharpened at its distal point, or leading turn, so as to facilitate penetration into the cardiac tissue. Each anchor 20 may be from about ten to about fifteen millimeters (mm) in total axial length. In some embodiments, the anchors 20 may be shorter or longer than ten to fifteen millimeters (mm) in total axial length. By “total” axial length it is meant the axial length of the anchor 20 from the end of the distal penetrating tip to the opposite, proximal end of the head 22.
  • the helical portion of the anchor 20 may be from about six to about twelve millimeters (mm) in axial length, i.e. in an axial direction. In some embodiments, the helical portion of the anchor 20 may be shorter or longer than six to twelve millimeters (mm) in axial length.
  • the anchor head 22 and/or other non-helical portions of the anchor 20 may be from about three to about four millimeters (mm) in axial length. In some embodiments, the anchor head 22 and/or other non-helical portions may be shorter or longer than three to four millimeters (mm) in axial length.
  • the anchors 20 are capable of extending from about four to about seven millimeters (mm) axially beyond the corresponding lower crown 16.
  • the helical portions of the anchors 20 may extend from four to seven millimeters (mm) into the cardiac tissue.
  • the frame 10 is shown with eight upper crowns 14 and eight lower crowns 16 and anchors 20, but this number of apices is shown for illustration purposes and may be varied, for example four upper and lower apices, sixteen upper and lower apices, etc.
  • each upper crown 14 is fitted with a collar 18 and each lower crown 16 has a respective anchor 20 threadingly received through the openings 17 of the anchor 20.
  • the anchors 20 couple with the lower crowns 16.
  • the anchors 20 may be in the general shape of a helix. As shown, the openings 17 receive helically wound anchors 20. The openings 17 are spaced to accommodate the pitch of the helical anchors 20, for example the spacing between the turns in the helix of the anchor 20. There may be a gap between the inner diameter of the openings 17 and the outer diameter of the anchor 20 to allow for free movement of the anchor 20 through the openings 17. There may be a small gap between the inner diameter of the openings 17 and the outer diameter of the anchor 20. In some embodiments, there may be an interference fit between the openings 17 and the anchor 20 or a varying pitch to provide interference between the anchor and frame.
  • FIGS. 2 through 4 illustrate the implant 1 in various stages of delivery and deployment.
  • the implant has been expelled from a delivery catheter and is in its unconstrained state above and proximate the cardiac valve annulus.
  • This unconstrained state may be a tissue engaging configuration of the implant 1 having a tissue engaging diameter and a tissue engaging height.
  • the frame 10 may have an overall axial height in the range of 15 to 20 millimeters (mm). This height or range of height will vary even further from this 15 to 20 mm range, depending on the number of apices and anchors 20. More specifically, the height is smaller with more apices and anchors 20 and is greater with fewer apices and anchors 20.
  • the frame has a height of approximately 17 millimeters. Other heights in the unconstrained state are possible, and this particular embodiment is not limiting of the scope of the present disclosure.
  • FIG. 3 depicts the implant after it has been anchored into the cardiac tissue.
  • This anchored state may be an anchored configuration, which may or may not be similar to the tissue engaging configuration, of the implant 1 having an anchored diameter and an anchored height.
  • the anchored diameter of the implant 1 may be less than, equal to, or greater than the tissue engaging diameter of the implant 1 in the tissue engaging configuration.
  • the anchored height of the implant 1 may be less than, equal to, or greater than the tissue engaging height of the implant 1 in the first configuration.
  • the anchors 20 have been rotationally advanced through the lower crowns 16 and the tissue piercing end has rotationally advanced into the cardiac tissue.
  • the abutments 24 function as a depth control for the anchors 20, limiting the extent of axial travel of the helical anchors 20 into the cardiac tissue as the abutments 24 seat in the valley bounded by the lower ends of the adjacent struts 12.
  • FIG. 4 shows the implant 1 in its contracted or cinched state.
  • This cinched state may be an annulus remodeling configuration of the implant 1 having an annulus remodeling diameter and an annulus remodeling height.
  • the annulus remodeling diameter of the implant 1 is less than the tissue engaging diameter of the implant 1 in the tissue engaging configuration.
  • the annulus remodeling height of the implant 1 may be greater than the tissue engaging height of the implant 1 in the tissue engaging configuration.
  • the collars 18 have been moved downwardly over the upper crowns 14 until inwardly biased locking tabs 19 engage with the gap or valley bounded by the upper portions of adjacent struts 12, below the underside of the upper crowns 14. This engagement of the locking tabs 19 to the valley under the upper crowns 14 locks the implant into its cinched position.
  • cut-outs may be formed on the upper crowns 14 to accept the locking tabs 19.
  • the implant 1 in it cinched state has a reduced circumference.
  • the cinched implant 1 has a reduced length perimeter or boundary relative to the unconstrained state.
  • the reduction in circumference need not result in the same general shape of the implant as before the cinching.
  • the implant 1 may be in a generally elliptical, oval or other shape, and after cinching the implant 1 may be in a general "D" shape or other shape (and with a relatively reduced circumference).
  • the implant 1 may be in a variety of shapes before or after cinching, as well as during cinching. For instance, restraints such as the collars 18 may be advanced individually, i.e. not simultaneously.
  • the implant 1 may thus have an irregular shape while being cinched. In some embodiments, even in the cinched state not all of the collars 18 are advanced, and/or are not all advanced the same amount, such that in the cinched state the angular displacements among different pairs of adjacent struts may not be the same.
  • the implant 1 may thus be cinched in a custom manner depending on the particular patient's needs. In some embodiments, about half of the implant 1 may be cinched, for example to bring the anterior native leaflet closer to the posterior native leaflet, or vice versa.
  • the "cinched" state of the implant 1 is not limited to only those particular shapes shown and described herein, but includes a multitude of possible shapes, sizes, etc. and which may be chosen based on needs of the patient.
  • FIGS. 5A through 5D are various views of an embodiment of a collar 50 that may be used with the implant 1.
  • the collar 50 is shown coupled with the struts 12 at the upper crown 14.
  • FIGS. 5A and 5B are front views of a portion of the implant 1, showing the collar 50 coupled with the upper crown 14 at different axial locations.
  • FIG. 5A shows the implant 1 in a unconstrained state.
  • FIG. 5B shows the collar 50 advanced distally relative to the position of the collar 50 shown in FIG. 5A to reconfigure the implant 1 in a cinched state.
  • FIG. 5C is a cross section view of the implant 1 taken along line 5C-5C of FIG. 5B .
  • FIG. 5D is a front view of the implant 1 showing a portion of a delivery tool engaging the implant 1.
  • the collar 50 has multiple locking tabs 54.
  • the locking tabs 54 may have the same or similar features and/or functionalities as other locking tabs described herein, for example the locking tabs 19, and vice versa.
  • the locking tabs 54 may be projections or cutouts of the collar 50.
  • the locking tabs 54 are biased toward the upper crown 14.
  • the locking tabs 54 may therefore contact the upper crown 14.
  • the upper crown 14 may include openings which can receive the ends of the locking tabs 54 therein.
  • the upper crown 14 may define a gap in between adjacent struts 12 at a valley, as described, which may receive the end of the locking tabs 54 therein. While two such locking tabs 54 are shown, it should be understood that three or more locking tabs 54 could be employed.
  • the plurality of locking tabs 54 allows the physician/user of the implant 1 to adjust the degree of cinch of the implant 1. Increased cinch, resulting in a smaller width of the implant 1 due to contraction, will tend to further reduce the width of the heart valve annulus.
  • FIGS. 5B and 5C depict the collar 50 advanced distally.
  • the collar 50 as shown may be in its fully advanced state, thus reconfiguring the implant 1 to a state of maximum cinch.
  • the uppermost locking tab 54 is engaging the underside of the upper crown 14.
  • cut-outs in the upper crown 14 itself can provide the locking engagement with tabs 54.
  • the collar 50 has a modified or cut out upper section to more readily receive a driver tube 56.
  • a string member 58 which could take the form of a wire, cable, thread, suture or the like, is used to apply tension to the upper crown 14 as the driver tube 56 advances the collar 50.
  • the driver tube 56 may be an elongated tube configured to contact and the collar 50 and to apply a downward pressure to the collar 50 to advance the collar 50 along the frame 10.
  • the string member 58 extends through an opening in the upper crown 14 to counteract the downward force applied by the driver tube 56. This allows the frame 10 to remain stationary axially while the collar 50 advances distally to reconfigure the struts 12 and cinch the implant 1.
  • FIG. 5E is a partial side view of the frame 10 coupled with a frequency generator 11.
  • the frequency generator 11 may be used with the various implants described herein, for example the implant 1, etc.
  • the frame 10 is shown with a slider or collar 50', a pull wire 58' and a pusher tube 56'.
  • the collar 50', pull wire 58' and/or pusher tube 56' may be analogous to the collar 50, the pull wire 58 and/or the driver tube 56, respectively.
  • a high-frequency vibration can be added by the frequency generator 11 to assist the movement of the collar 50'.
  • relative vibrational movement between the collar 50' and the frame 10 may produce dynamic movement that facilitates overcoming a static friction between the collar 50' and the frame 10.
  • the vibration could be transmitted through the pull-wire 58' and/or the pusher tube 56'. Vibration of either or both the pull-wire 58' or the pusher tube 56' will transmit the force to the frame 10 and collar 50' vibrating the frame 10 and collar 50' at a frequency to allow an easier movement between the frame 10 and collar 50'. An additional tensioning of the pull-wire 58' during the advancement will provide a force to the frame 10, changing the frame 10 upper apex shape from a wide angle to a more acute angle thus lessening the force required to advance the collar 50'. This combination of pull-force and vibration will lower the push-pull forces required to advance the collar 50' over the frame 10.
  • the frequency transmitted through the tensioning wire and/or pusher tube 56' will lower these forces and could be coupled through each connection.
  • a variety of suitable frequency generator tools could be used as the frequency generator 11 to transmit these vibrational frequencies, such as a CUSA system (Integra ® CUSA° EXcel+ Ultrasonic Tissue Ablation System).
  • the frequency may be, for example, from 1 to 100 KHz.
  • the frequency can be varied during the procedure, tailored during the procedure or provided at a fixed defined frequency.
  • FIGS. 6A and 6B depict an alternate embodiment of the frame 10 and the frame/collar interaction.
  • the frame 10 is further provided with mid-struts 64.
  • the mid-struts 64 have crowns 68 and bridge the gap between lower apices 16.
  • Locking tabs 62, of collars 60 engage with mid-strut crown 68 as collar 60 is advanced by operations of wire 58 and driver tube 66.
  • the mid-strut crown 68 may be pulled proximally by the wire 58 to engage the locking tabs 62.
  • the locking tabs 62 engage with the underside of mid-strut crowns 68 reducing the diameter of the frame 10 and cinching and locking the implant as shown in FIG. 6B .
  • the collars 60 have sections removed along their sides from proximate mid collar to the collar distal end to accommodate movement of struts 12 as the collar is advanced over the mid-strut crown 68. Also, it is understood that rather than engaging with the underside of mid-strut crown 68, cut-outs could be provided in the surface of the mid-strut crowns 68.
  • a driver tube 66 may act to drive the collar 60.
  • the collar 60, locking tabs 62 and driver tube 66 may have the same or similar features and/or functionalities as, respectively, the collar 50, the locking tabs 54, and the driver tube 56, and vice versa.
  • FIGS. 7A through 7D are various views of another embodiment of a collar 70 that may be used with the various devices, systems and methods described herein.
  • the collar 70 may have the same or similar features and/or functionalities as the other collars described herein, and vice versa.
  • FIGS. 7A, 7B, 7C and 7D show, respectively, a circumferentially outward facing view, a side view, a circumferentially inward facing view, and a perspective view of the collar 70.
  • the collar 70 includes locking tabs 72, 74.
  • the locking tabs 72, 74 are on opposing sides of the collar 70.
  • Two cut-outs 76 are located proximate the midsection of the sides of the collar 70. There may be only one or more than two cut-outs 76.
  • Flex sections 78 are provided on either of the lower sides of the collar 70.
  • the lower tab 74 acts as a safety tab.
  • the lower tab 74 is positioned into engagement with a cut out in the upper crown 14, or, alternatively, the underside of the upper crown 14, of the implant 1. This may, for example, keep the collar 70 engaged with the upper crown 14 during the rigors of packaging and shipping and during the surgical procedure itself.
  • both tabs 72, 74 can act as safety tabs by having multiple cut outs on either side of the upper crowns 14.
  • the cut outs 76 are created for preferential forming of the collar 70.
  • a starting material of a round hypotube may be crushed or swaged into an oval shape to slide the collar 70 over the upper crowns 14.
  • the flex sections 78 may reduce friction when the collar 70 is being advanced over the struts 12. The flex sections 78 may also minimize scraping of the collar 70 against the struts 12 of the frame 10 when the collar 70 is advanced. Additionally, as best seen with reference to FIG. 7D , when the collar 70 is advanced such that the upper locking tab 72 is engaged with the underside of an upper crown 14, the lower, inwardly biased tab 74 will help support upper tab 72 when it is advanced into locking engagement with the upper crown 14.
  • FIGS. 8A through 8C illustrate another embodiment of a collar 80 that may be used with the various devices, systems and methods described herein.
  • the collar 80 also referred to as a "slider,” may have the same or similar features and/or functionalities as the other collars described herein, and vice versa.
  • FIG. 8A is a front view of the slider or collar 80
  • FIG. 8B is a side view of the collar 80
  • FIG. 8C is a perspective view of the collar 80.
  • This variation of the collar 80 is also provided with preferential forming cut outs 86 and flex sections 88, which may be similar or the same as the cutouts 76 and flex sections 78 as described with reference to the collar 70 in FIGS. 7A through 7D .
  • locking tabs are not provided on the collar 80. Rather, tabs are instead provided on the upper crown 14 (not shown) for locking engagement with cut outs 82 on the collar 80. These tabs would extend outwardly from the upper crown 14 and be downwardly biased.
  • FIG. 9 is a perspective view of another embodiment of a slider or collar 90.
  • the collar 90 is provided with radial locking tabs 92.
  • Locking tabs 92 are located on the sides of the collar 90 and are inwardly biased to engage with grooves (not shown) on the sides of the upper crowns 14 of the frame 10. Multiple levels of such grooves may be formed on the upper crown 14, and in addition or alternatively can be provided on the upper portions of the struts 12. Such grooves in either or both locations allow for more varied degrees of cinching of the implant 1.
  • FIGS. 10 through 15 are perspective views of various embodiments of implants that may be used with the various systems and methods described herein.
  • FIGS. 10 through 15 only some of the same features may be labeled for clarity.
  • FIGS. 10 and 11 are perspective views of an embodiment of an implant 100.
  • the implant 100 may have the same or similar features and/or functionalities as other implants described herein, for example the implant 1, and vice versa.
  • the implant 100 is shown in an embodiment of an unconstrained state in FIG. 10 .
  • the implant 100 is shown in an embodiment of an anchored, cinched and locked state in FIG. 11 .
  • the implant 100 includes a frame 100 having struts 112, upper crowns 114, lower crowns 116 and anchors 120. These may be analogous to, for example, the frame 10, the struts 12, the upper crowns 14, the lower crowns 16, and the anchors 20, respectively. By “analogous” it is meant these features may have the same or similar features and/or functionalities as each other.
  • the implant 100 has, in accordance with the invention, lower crowns 116 that are inclined at an angle with respect to the struts 112. The lower crowns 116 may be inclined downward and outward, or distally and outward, relative to the struts 112 and/or relative to the axis (shown in FIG. 10 ).
  • the anchors 120 may be directed more in a direction into the annular tissue above and proximate the heart valve, and less in a downward direction toward the valve leaflets.
  • the angle may be measured between the direction the lower crowns 116 extend and a portion of the axis extending underneath the implant 100.
  • the angle may also be measured between the direction the lower crowns 116 extend and the direction that the struts 112 extend downward. This angle may be between thirty to sixty degrees. In some embodiments, this angle is approximately forty-five degrees.
  • the anchors 120 are formed as one piece. A variety of different types of anchors may be used with the implant 100.
  • FIGS. 10 and 11 include opposing tab sliders or collars 118.
  • the collars 118 may be analogous to the collars 70, described with respect to FIGS. 7A through 7D .
  • FIGS. 12 and 13 are perspective views of an embodiment of an implant 101.
  • the implant 101 may have the same or similar features and/or functionalities as the implant 100, and vice versa.
  • the implant 101 is shown in an embodiment of an unconstrained state in FIG. 12 .
  • the implant 101 is shown in an embodiment of an anchored, cinched and locked state in FIG. 13 .
  • the implant 101 has upper crowns 124 having locking tabs 130.
  • the implant 101 also includes indexed sliders or collars 128.
  • the collars 128 may be analogous to the collars 80 described with respect to FIGS. 8A through 8C .
  • the tabs 130 are provided on the upper crowns 124 for locking engagement with the grooves formed in the collar 128. Such grooves may be similar to the grooves 82 of the collar 80.
  • FIGS. 14 and 15 are perspective views of an embodiment of an implant 102.
  • the implant 102 may have the same or similar features and/or functionalities as the implant 100 and/or 101, and vice versa.
  • the implant 102 is shown in an embodiment of an unconstrained state in FIG. 14 .
  • the implant 102 is shown in an embodiment of an anchored, cinched and locked state in FIG. 15 .
  • the implant 102 includes radial locking collars 148.
  • the collars 148 may be analogous to the collars 90, described with respect to FIG. 9 .
  • Radially inwardly biased locking tabs 149 on the collars 148 engage with grooves 150 cut into the outer sides of the upper crowns 144.
  • the pitch of the helically wound anchors 120 can be varied.
  • the pitch of the last turn of the anchors 120 may also be varied, for example to self-lock the anchors 120 into the lower crowns 116.
  • the last or most distal turn of the helical anchors 120 may be swaged from a circular cross section to a more oval cross section to prevent backing out of the anchors 120 from the lower crown 116, for example to prevent backing out after engagement or anchoring in the heart tissue.
  • pitch of the most distal turn of the helical anchors could be varied to prevent backing out.
  • FIGS. 16 and 17 are side views of a portion of an implant 103 in an uncinched and cinched state, respectively. The views indicate an embodiment of a method for cinching the implant 103 after anchoring.
  • the implant 103 may be analogous to the various implants described herein, for example the implant 1, etc.
  • the implant 103 includes a frame 160.
  • the frame 160 may be analogous to other frames described herein, for example the frame 10, etc.
  • the frame 160 has lower apices 166 which include eyelets 168.
  • a string 172 is attached to or fed through the eyelets 168. Alternatively, the string 172 can carry enlargements, knots, and the like at its ends to prevent the ends from passing through the eyelets 168 as the frame 160 is cinched.
  • String 172 can be made of wire, cable, suture, thread, or the like.
  • Rotational member 170 is either fixedly attached to string 172 or string 172 is passed through a tunnel formed in the end of rotational member 170.
  • FIG. 16 shows frame 160 in an unconstrained state.
  • FIG. 17 shows the frame in its implanted state. After anchoring, the rotational member 170 is rotated thereby winding string 172 about the member 170. This action causes the gap between lower apices 166 to shorten thereby cinching, or reducing the diameter, of the frame 160.
  • FIGS. 18 and 19 show a variation of the implant 103 of FIGS. 16 and 17 .
  • a string 180 is provided in FIGS. 18 and 19 .
  • the string 180 can take the form of a thread, suture, or the like.
  • the string 180 is attached to a string 182 by way of loop or knot 188.
  • the string 182 is similar to the string 172 shown in FIGS. 16 and 17 .
  • FIG. 18 shows the frame 160 in an unconstrained state
  • FIG. 19 shows the frame 160 being brought towards a cinched state.
  • the knots 184 will click, one by one, through an eyelet 186 in the upper crowns 187.
  • the knots 184 are sized so to be able to be pulled through the eyelet 186, but cannot reverse back through the eyelet 186. In this manner, the knots 184 provide a locking function and multiple degrees of cinch of the frame 160. After the desired degree of cinching has been achieved, the proximal ends of the string 180 are secured to maintain tension and then cut and the ends removed from the system.
  • FIG. 20 is a partial side view of another embodiment of an implant 104.
  • the implant 104 may be analogous to the other implants described herein, for example the implant 1, etc.
  • the implant 104 includes features for cinching the frame 160.
  • a string-like member 202 is passed through multiple eyelets 204 disposed on the lower apices 166.
  • the string-like member 202 extends circumferentially about the lower section of the frame 160.
  • a driver unit (not shown) can be used to grab and gather the string-like member 202 until the desired amount of reduction in the diameter of the frame 160, or cinching, is achieved.
  • other features described herein may be used with the string-like member 202 to cinch the string-like member 202, for example the string 180 or the rotational member 170.
  • FIGS. 21A through 21D are partial side views of an embodiment of a frame 210 that may be used with the various implants described herein, for example the implant 1, etc. The views sequentially show a technique for cinching the frame 210.
  • the frame 210 has struts 212, upper crowns 214 and lower crowns 216, which may be analogous, respectively, to other struts, upper crowns and lower crowns described herein.
  • a central projection 218 extends downwardly from the upper crown 214 into the gap or valley bounded by adjacent struts 212.
  • the central projection 218 includes three tabs 220. There may be fewer or greater than three tabs 220.
  • the tabs 220 extend in an upwardly oriented and angled direction, e.g. outward, from the central projection 218.
  • a string member 222 spans the distance between adjacent lower apices 216.
  • the string member 222 may be between one, some or all distances between pairs of adjacent lower apices 216.
  • the string member 222 can take the form of a wire, cable, suture, thread, or the like.
  • the string member 222 is passed through one or more holes 224 in the lower crowns 216.
  • the holes 224 are sized and positioned so as not to interfere with the rotation of helical anchors 232 as they are threadingly advanced through the holes 234 (see FIG. 21C ).
  • the anchors 232 may be analogous to other anchors described herein, for example the anchors 20, etc.
  • the ends of the string members 222 may be knotted, for example for thread or suture string members 222.
  • the ends of the string members 222 may be provided with a weld ball, collar, etc. crimped onto its ends, for example if the string members 222 are wire or cable. Such end features may prevent the ends of the string members 222 from being pulled through the holes 224 when tension is applied.
  • a driver tube 226 is operated to apply tension to pull wire 230.
  • an alignment feature 228 can be provided to align pull wire 230 with central projection 218 and its tabs 220.
  • FIG. 21D shows the frame in one particular state of cinch.
  • the string member 222 may be engaged with any of the tabs 220 to provide more or less cinching to the frame 210.
  • FIGS. 22A and 22B are perspective views of an embodiment of a distal end of a delivery catheter 40 being used to deliver an implant 1A.
  • the delivery catheter 40 has various positioning and imaging capabilities. The distal end of the delivery catheter 40 is maneuvered into position above the heart valve annulus.
  • the delivery catheter 40 may be used to deliver the various implants described herein, for example the implant 1, etc.
  • the implant 1A shown being delivered in FIGS. 22A-22B is for resizing the heart valve annulus. It is understood that a variety of different implants may be delivered with the delivery system and methods described herein.
  • the implant 1A may be analogous to the other implants described herein, such as the implant 1.
  • this particular implant 1A includes a frame 250.
  • the frame 250 has anchors 20 attached to a lower or distal portion of the frame 250 and extending distally therefrom.
  • the frame 250 has an upper or proximal portion with collars 252 extending over upper crowns 251 of the frame 250. Only some of the collars 252, upper crowns 251 and anchors 20 are labelled for clarity.
  • the collars 252 may be moved, e.g. distally, along the frame 250 by driver tubes 260 to resize the frame 250.
  • the frame 250, upper crowns 251 and collars 252 may be analogous to the various frames, upper crown and collars described herein, such as the frame 10, upper crowns 14 and collars 18, and vice versa.
  • the frame 250, one or more driver tubes 260, and an intravascular cardiac echography (or "ICE") catheter 270 may be extended from the distal end of the delivery catheter 40.
  • the frame 250 and driver tubes 260 may be analogous to the various frames and driver tubes described herein.
  • the driver tubes 260 are shown engaging corresponding upper crowns 252 of the frame 250.
  • a centering frame 280 maintains concentric positioning of the ICE catheter 270 relative to the frame 250 during deployment, alignment and positioning of the frame 250 above and proximate to the target heart valve annulus tissue.
  • the centering frame 280 maintains a generally centered position of the catheter 270 relative to the frame 250.
  • the operator need only rotate the ICE catheter 270 to view each anchor 20 and placement of the anchors 20.
  • the ICE catheter 270 could be used to view various other individual features of the implant 1A, such as the collars 252, for instance to view the extent to which each collar 252 is advanced down and over upper crowns 251 of the frame 250, to more precisely adjust the size of the frame 250.
  • the ICE catheter 270 could also provide significant benefit to an embodiment where a singular cinching mechanism or driver tube needs to be landed on each crown 251 of the frame 250 to adjust the sizing of the frame 250.
  • An indexing feature (not shown) may also be provided on the ICE catheter 270, for example, such that actuation of the indexing feature by the operator causes the ICE catheter 270 to automatically move, or rotate, to the next anchor 20 position.
  • FIGS. 22C and 22D are perspective views of an embodiment of an implant 1B being delivered and implanted by the delivery catheter 40.
  • the implant 1B may be analogous to the various implants described herein, such as the implants 100, 101, 102, and vice versa.
  • the implant 1B includes a frame 10 with struts 12 forming upper apices or crowns 14 and lower apices or crowns 16.
  • the lower crowns 16 have openings 17, such as holes, aligned to receive the anchors 20 there through.
  • the anchors 20 may be rotated to move distally through the openings 17.
  • the implant 1B is intended to be delivered proximate to and above a cardiac valve (tricuspid, mitral) annulus, and subsequently implanted in the annular cardiac tissue just above the plane of the valve orifice.
  • Driver tubes 22' having proximal portions 22" extending out of the delivery catheter 40, are provided for rotationally engaging the anchors 20.
  • Manipulation, for example rotation, of the driver tubes 22' by the operator causes the anchors 20 to advance towards, engage with and penetrate cardiac tissue to secure frame 10 into the annulus approximate and above the valve.
  • the anchors 20 may be advanced individually one at a time, some advanced together, or all advanced together.
  • the driver tube 22' may rotate relative to the proximal portion 22".
  • the driver tube 22' and proximal portion 22" are part of the same, continuous driver tube and/or the entire tube 22' and proximal portion 22" may rotate together.
  • the ultrasound catheter 30 may be analogous to the ICE catheter 270.
  • by rotating the ultrasound catheter 30 around the inside of the valve annulus, the relative position of the frame 10, and of any valve leaflets, will be seen for accurate positioning of the anchors 20 around and above the valve annulus.
  • the ultrasound catheter 30 is contained within and advanced down an offset, non-central lumen of the delivery catheter 40. In this manner, the ultrasound catheter 30 would not interfere with the frame 10, its attachments or other featues, and the driver components.
  • the ultrasound catheter 30 may be located and steered to the side of the annulus to image, allowing for less rotation to more quickly view the anchor points of the frame 10.
  • An offset lumen could exit more proximally with regard to the distal end of the delivery catheter 40. This more proximal exit would reduce the overall profile or diameter of the distal end of the delivery catheter 40. In addition, this more proximal exit port would enable a view of the valve annulus from above.
  • the offset lumen could also be compressible allowing for an even smaller profile until the ultrasound catheter 40 is advanced through the offset lumen.
  • ultrasound catheter 30 is shown integrated into the same delivery system as the delivery catheter 40, in some embodiments the ultrasound catheter 30 could otherwise be introduced secondarily through another entry site, such as through the aortic valve, and placed near or inside the implant for imaging and placement of the anchors 20.
  • FIG. 22E is a perspective view of an embodiment of a centering frame 32 coupled to the ultrasound catheter 30 and to an implant 1C.
  • the implant 1C may be analogous to other implants described herein, such as the implants 1, 1A, 1B, and vice versa.
  • the centering frame 32 has centering arms 34 connected to a centering hub 36 that is mounted on the ultrasound catheter 30. As the distal end of the delivery catheter 40 is maneuvered into position above the heart valve annulus, the centering frame 32 maintains concentric positioning of the ultrasound catheter 30 relative to the frame 10 during deployment, alignment and positioning of the frame 10 above and proximate to the target heart valve annulus tissue.
  • the centering aspect is desirable, for example, because if the ultrasound catheter 30 remains centered within the frame 10, the operator such as a surgeon or technician need only rotate the ultrasound catheter 30 to view each anchor 20 and placement the of each anchor 20. There may also be an indexing feature (not shown) on the ultrasound catheter 30 such that actuation of the indexing feature by the operator causes the ultrasound catheter 30 to automatically move, or rotate, to the next anchor position.
  • the centering frame 32 may be used with delivery of the various implants described herein, such as the annulus resizing implants and/or the heart valve replacement implants.
  • FIG. 23 is a side view of an embodiment of an ICE catheter 270.
  • the ICE catheter 270 as shown includes a guidewire entry port 292 and a guidewire exit port 294 which together accept the guidewire 296.
  • This embodiment allows the ICE catheter 270 to be delivered separately from the frame 10 thereby reducing the overall diameter of the delivery catheter 40 (e.g. as shown in FIGS. 22A and 22B ).
  • An ICE handle may be located at a proximal end of the catheter 270.
  • An ICE array may be located at the distal end of the catheter 270.
  • a separately delivered ultrasound catheter 270 could be functionally linked to the distal end of the delivery catheter 40 and to the inside of the frame 10.
  • the delivery catheter 40 could have mechanical docking and radiopaque features to aid in delivery and stability of the ultrasound catheter 270 relative to the delivery catheter 40.
  • FIGS. 24A , 24B , 24C and 24D depict an embodiment of an ICE catheter 300 that may be used with the various implants and delivery devices, systems and methods described herein.
  • the ICE catheter 300 has radial ultrasonic transducers 302, circumferential ultrasonic transducers 304 and guidewire 306 passing centrally therethrough.
  • a guidewire lumen 303 extends out from a delivery catheter 240.
  • the delivery catheter 240 may be analogous to the delivery catheter 40.
  • the ICE catheter 300 extends out through the guidewire lumen 303.
  • FIGS. 24B and 24C show the implant 1 deployed with the ICE catheter 300 tip.
  • FIG. 24C further shows the relationship of the ICE catheter 300 to the delivery catheter 240 while it is taking a radial echo view to properly position the anchor 20 for insertion into heart valve annulus tissue.
  • FIG. 24C shows the ICE catheter 300 capturing a circumferential echo image for properly positioning the frame 10 in a plane above the heart valve and its leaflets.
  • the features shown and described in FIGS. 24A-24D may be used to deliver various other implants, such as other resizing devices or heart valve replacement valves.
  • software or electronic controls can be effective to cycle through the radial cross sectional images around the valve annulus perimeter, relieving the need to physically move, via rotation, translation or deflection, the ICE catheter 300.
  • a larger circumferential transducer array could also be placed distal of the annulus to not interfere with space limitations of the delivery catheter 240, further decreasing the profile of the delivery catheter 240.
  • the transducers of the ICE catheter 300 could generate a three dimensional image of the annulus of frame 10. The user could then more readily see the relative alignment of the annulus, valve leaflets and the implant 1.
  • FIGS. 25A through 25E are sequential perspective views of an embodiment of a delivery system 401 with imaging capability showing an embodiment of a method for the delivery, positioning and anchoring of the various implants described herein for resizing the native valve annulus. While FIGS. 25A through 25E depict delivery of the implant 1 for resizing the annulus, it is understood that implants for replacing the valve may also be delivered with the system 401.
  • the implant 1 may be delivered, positioned and anchored to reshape the valve annulus.
  • the implant 1 may be inserted using the delivery system 401 via access to the vasculature of the leg, in particular the femoral vein or the iliac vein.
  • the system 401 may include the various implants, catheters and other features described herein, for example the implant 1, the delivery catheter 240, the ICE catheter 300, the guidewire 306, etc.
  • the system 401 may include any of the implants described herein, for example implants including valve annulus reshaping devices or valve replacements that include valve leaflets.
  • FIG. 25A the system 401 is then advanced across the septum separating the upper chambers of the heart.
  • the ICE catheter 300 is advanced to a position above the heart valve annulus, for example, the mitral valve annulus, as shown in FIG. 25B .
  • FIG. 25C shows the implant 1 expelled from the distal end of the delivery system 401 above and proximate to the mitral valve annulus.
  • a series of radial images are taken to properly position the anchors 20 for insertion into the mitral valve annulus tissue, as shown in FIG. 25D .
  • a circumferential image is captured, as shown in FIG. 25E , to confirm that all anchors 20 are appropriately placed and anchored in the mitral valve annulus tissue above the mitral valve leaflets.
  • one or more anchors 20 are not positioned or anchored properly, they can be rotationally retracted, repositioned and re-anchored prior to removal of the driver tubes. In addition, a circumferential image can be taken prior to anchoring to confirm location of the lower crowns 16 of the frame 10 of the implant 1. It should also be understood that treatment of the tricuspid valve could involve insertion of the system 401 for access through the jugular vein whereby the system is then advanced down the superior vena cava and into the right atrium proximate and above the tricuspid valve annulus.
  • FIG. 26 is a perspective view of an embodiment of an implant 100 having a constricting loop 320.
  • the implant 100 is shown interacting with a delivery system for advancing the collars 60.
  • the constricting loop 320 may be used with other embodiments of the implant described herein, for example the implants 101, 102, etc.
  • the constricting loop 320 is provided.
  • the constricting loop 320 encircles the frame 110 proximate the lower crowns 16.
  • the constricting loop may encircle upper portions of the lower crowns 16 as shown, or other portions.
  • a constricting loop actuator 330 may be provided to act on and constrict the constricting loop 320.
  • the actuator 330 may include a wire with a loop through which the constricting loop 320 extends, and where pulling the wire proximally will constrict and tighten the constricting loop 320 about the frame 110.
  • the constricting loop 320 may be actuated first, allowing the operator to first predetermine the desired diameter of the frame 110.
  • the collars 60 may then be advanced, cinching the frame 110 and locking it in the desired diametric dimension. In some embodiments, other collars described herein may be implemented.
  • the constricting loop 320 is then removed. Constricting the frame 110 also reduces resistance to advancement of the collars 60. Furthermore, the constricting loop 320 assists in collapsing the frame 110 into the distal portion of the delivery catheter.
  • the constricting loop 320 helps reduce friction between the flared lower crowns 16 and the inner diameter of the delivery catheter. Additionally, a proximal loop can be utilized to restrict the proximal portion of the frame 110 to change the angle at which the anchors address the valve annulus.
  • FIG. 27A is a perspective view of an embodiment of an implant 105 having a cinch loop 340.
  • the implant 105 does not include collars and the cinch loop 340 is provided to cinch and lock the frame of the implant 105 in the target heart valve annulus tissue.
  • the cinch loop 340 is tightened down by operation of a cinch loop driver 350.
  • FIG. 27B is a detail view showing a close up view of the driver 350 interacting with the loop 430.
  • the driver 350 may include an inner tube or member 351 extending therethrough to or near a distal opening of the driver 350.
  • a distal member 352, such as a wedge, may be attached to the distal end of the inner tube 351.
  • the distal member 352 removably attaches to an element 353, for example by threaded engagement, friction fit, or other suitable engagement means.
  • the loop 340 extends through or is otherwise attached to the element 353, locking the loop 340 in place. Pulling the element 353 in the proximal direction, for example by moving the driver 350 proximally, and/or pulling the inner tube 351 proximally, the loop 340 reduces in circumference around the implant 105, cinching the frame to a smaller diameter. The ends can then be snipped and driver 350 and inner tube 351 withdrawn. Once the operator has achieved the desired reduction in diameter of the anchored frame, the cinch loop 340 is locked in place and the cinch loop driver 350 is removed.
  • the cinch loop 340 may engage with the frame 110, for example with the lower crowns 16, to lock in place. Such engagement may be by friction fit, openings in the lower crowns 16 that allow for unidirectional movement of the loop 340, or other suitable means.
  • FIG. 28 is a perspective view of a delivery system 400 that may be used to deliver the various implants described herein.
  • the delivery system 400 comprises a steerable sheath 402, a sheath steering nob 404, cinch knobs 406, anchor knobs 408, the implant 100 which may be any implant described herein, the ICE probe 270, all supported and secured to a base 410.
  • the cinch knobs 406 and anchor knobs 408 are all spring loaded to maintain tension. Rotation of the anchor knobs 408 rotationally advance the helically wound anchors 20 into the annular tissue above the target heart valve.
  • Cinch knobs 406 are manipulated by the operator to advance the collars and lock the frame of the implant 100 into a cinched position.
  • FIG. 29 is a cross section taken along line 29-29 of FIG. 28 .
  • the pull wires 412 are attached to the sheath steering knob 404 to deflect the distal end of the sheath 402.
  • the sheath 402 may be a steerable outer sheath 402, for example made of braided polymer or metal such as Nitinol or stainless steel.
  • the ICE catheter shaft 270 may be centrally located with the guidewire lumen 303 located within the ICE catheter lumen 271.
  • anchor driver wires 403 for example nitinol, circumferentially located within the sheath 402.
  • the anchor driver wires 403 are located within anchor driver sheaths, for example laser cut hypotubes.
  • the pusher tubes 56' may be braided, located around the ICE catheter shaft 270.
  • the pusher tubes 56' may include a cinch retaining tube 404, for example a laser cut hypotube and a cinch retaining wire 407, for example nitinol.
  • FIGS. 30A-30C are perspective views of an embodiment of an expandable replacement valve implant 500 shown in various states, i.e. configurations.
  • FIG. 30A shows the replacement valve implant 500 in an unconstrained state.
  • FIG. 30B shows the replacement valve implant 500 in a deployed and anchored state.
  • FIG. 30C shows the replacement valve implant 500 in an anchored and cinched state.
  • the replacement valve implant 500 may be delivered with the various delivery systems and methods described herein.
  • the replacement valve implant 500 may include an associated cinching structure.
  • the replacement valve implant 500 is thus suited to treat multiple disease conditions.
  • the replacement valve implant 500 can treat mitral regurgitation developed as a consequence of cardiomyopathy and attendant dilation of the mitral valve annulus.
  • the replacement valve implant 500 and cinching structure can treat failed or defective heart valve leaflets by replacing the native valve apparatus.
  • the replacement valve implant 500 and cinching structure can treat both mitral regurgitation and those patients with concomitant defects in the valve leaflets themselves.
  • the replacement valve implant 500 includes one or more non-native valve leaflets 502.
  • the leaflets 502 may be mechanical or tissue-based such as porcine or bovine.
  • the leaflets 502 replace the function of the defective heart valves by providing normal or otherwise acceptable blood flow regulation.
  • the leaflets 502 may be configured to mimic the natural configuration of native leaflets. As shown, there are three leaflets 502. In some embodiments, there may be one, two, three or more leaflets 502.
  • the leaflets 502 are coupled with housing and/or other features of the replacement valve implant 500, as described herein.
  • the replacement valve implant 500 includes an inner valve housing 510.
  • the valve housing 510 may be a support for various features of the implant 500, such as the leaflets 502, one or more frames, struts, etc.
  • the valve housing 532 is configured to extend into the valve annulus and contain the leaflets 502 therein.
  • the leaflets 502 may be mechanically attached to the inner valve housing 510 by a variety of suitable means, including sutures, fasteners, adhesives, crimping, other means, or combinations thereof.
  • the valve housing 510 forms an inner portion of the replacement valve implant 500 that connects with an outer portion, as described herein.
  • the valve housing 510 may include an inner frame 508 and/or an inner barrier 519, as described herein.
  • the inner frame 508 may be analogous to other frames described herein, such as the frame 10, and thus be a structural member, include a tubular shape, have sinusoidal struts, etc.
  • the inner frame 508 may be a variety of suitable materials, such as metal, preferably nitinol. After deployment from a delivery catheter and expansion to the unconstrained shape, the inner frame 508 may or may not change shape, size, etc.
  • the inner frame 508 may be coupled with an outer frame 512, as described herein. Lower apices of the inner frame 508 may be coupled with lower apices of an outer frame 512.
  • the inner frame 508 may be a portion of the outer frame 512.
  • the inner frame 508 may be part of the same continuous structure as the frame 512 and form an inner portion thereof.
  • the inner frame 508 may be coupled to or otherwise carry the inner barrier 519 to form the valve housing 510.
  • the inner barrier 519 is a membrane-like material extending around the circumference of the valvehousing 510.
  • the inner barrier 519 is configured to extend into the valve annulus to contain the leaflets 502 within the annulus.
  • the inner barrier 519 also acts to prevent leakage of blood flow around the replacement valve implant 500.
  • the inner barrier 519 may comprise any of a variety of suitable materials, including ePTFE or a polyester material, such as Dacron.
  • the inner barrier 519 may be coupled with the inner frame 508.
  • the inner barrier 519 may be coupled with the inner frame 508 with a variety of suitable means, for example with sutures, mechanical attachments, embedding, other suitable features, or combinations thereof.
  • the inner barrier 519 may be carried by the radially inwardly or outwardly facing surfaces of the inner frame 508. As shown, separate segments of the inner barrier 519 may be coupled with the inner frame 508 in between struts of the inner frame 508. In some embodiments, the inner barrier 519 may be a single, continuous tubular membrane. For example, the inner barrier 519 may be provided entirely or mostly on the inside or internal diameter of the valve housing 510. In some embodiments, the inner barrier 519 may be provided entirely or mostly on the outside or external diameter of the valve housing 510. In some embodiments, there may be multiple barriers 519, such as an internal and an external inner barrier 519 each on opposite sides of the inner frame 508.
  • the illustrated replacement valve implant 500 includes an outer cinch frame 512.
  • the outer frame 512 is coupled with one or more anchors 516 and one or more restraints such as collars 518.
  • the outer frame 512, anchors 516 and collars 518 may be analogous to any of the other frames, anchors and collars described herein, for example the frame 10, anchors 20 and collars 18, respectively.
  • the outer frame 512 may thus include a tubular shape, having a sidewall comprising sinusoidal or zigzag struts, with restraints, etc.
  • the outer frame 512 may be coupled with the inner frame 508, for example at lower crowns 521 as shown.
  • the outer frame 512 may be coupled with the inner frame 508 in other manners, such as at upper crowns, etc.
  • the inner and outer frames 508, 512 may be part of the same monolithic material, for example different portions of a single, continuous wire or laser cut frame, etc.
  • the outer frame 512 may compress for delivery within a delivery catheter, expand upon deployment from the catheter, and contract upon advancement of collars 518, as described herein. Contraction of the outer frame 512 may resize and/or re-shape the valve annulus. Activation of the restraints and/or manipulation of a control such as a pull wire advances the proximal end of the outer frame 512 radially inwardly toward the axis to reduce the inner diameter of the native valve annulus.
  • the anchors 516 may be located along a proximal end of the outer frame 512, as shown. In some embodiments, the anchors 516 may be in other locations along the circumference of the implant 500, for example located farther distally, located along the distal end of the implant 500, etc.
  • the anchors 516 are inclined radially outward in the distal direction as deployed from the head of the anchors to the tissue-penetrating tips of the anchors. In some embodiments, the anchors 516 may have other orientations, for example substantially parallel to the axis, radially outward substantially transverse to the axis, inclined in the proximal or distal directions, or combinations thereof.
  • the anchors 516 may engage either the inner frame 508 or the outer frame 512 of the implant 500, such as at a strut or apex of the outer frame 512.
  • the anchors 516 act to secure the replacement valve implant 500 to tissue such that the replacement valve implant 500 extends through the native annulus and across the native valve.
  • the anchors 516 may be helical as described herein and rotatably engage the tissue.
  • the anchors 516 are shown retracted or pre-anchored in FIG. 30A .
  • FIG. 30B the anchors 516 have been advanced into a tissue engagement orientation.
  • FIG. 30C the outer frame 512 has been cinched such that the anchors 516 have now pulled the valve annulus inward to reduce the circumference of the annulus to conform to the implant 500 and reduce or eliminate the perivalvular space.
  • the collars 518 may be advanced along the outer frame 512 to adjust the circumference of the outer frame 512.
  • the collars 518 may be advanced along upper or lower crowns of the outer frame 512. As shown, the collars 518 are coupled with the lower crowns 521.
  • the collars 518 may be advanced along the lower crowns 521 similarly as described herein, for example, with respect to the implant 1 of FIGS. 1-4 , etc.
  • the replacement valve implant 500 may include an outer barrier 517, which may be analogous to the inner barrier 519 of the valve housing 510.
  • the outer barrier 517 of the frame 512 may be a material such as ePTFE or polyester, and may be selected to encourage or inhibit endothelial ingrowth.
  • the outer barrier 517 may be elastic such that it can stretch and/or contract to reduce or prevent bunching or wrinkling of the material during and after delivery, deployment and cinching of the outer frame 512.
  • the outer barrier 517 may be carried on the radially inwardly or outwardly surface of the outer frame 512. As shown, separate segments of the outer barrier 517 may be coupled with the frame 512 in between struts of the outer frame 512.
  • the outer barrier 517 may be a single, continuous membrane.
  • the outer barrier 517 may be provided on the inside or internal diameter of the outer frame 512.
  • the outer barrier 517 may be provided on the outside or external diameter of the outer frame 512.
  • the outer frame 512 and/or barrier 517 may form a generally frustoconical shape in the unconstrained state, as shown in FIG. 30A .
  • the struts of the outer frame 512 and the barrier 517 are inclined outward in the proximal direction relative to the longitudinal axis of the replacement valve implant 500.
  • the proximal edge of the barrier 517 is located radially farther outward relative to the distal edge of the barrier 517 in the unconstrained state.
  • the outer frame 512 and/or outer barrier 517 may contact various portions of the native heart anatomy after deployment from the delivery catheter, such as the annulus wall.
  • the outer frame 512 and/or outer barrier 517 may still be in a generally frustoconical shape, as shown in FIG. 30B , leaving a perivalvular annular space but blocking perivalvular blood flow by the outer barrier 517 and/or inner barrier 519.
  • the outer frame 512 and/or outer barrier 517 may form a generally cylindrical shape, as shown in FIG. 30C .
  • the outer frame 512 and/or outer barrier 517 may form other shapes, such as a generally frustoconical shape, other non-cylindrical shapes, etc.
  • the replacement valve implant 500 shown in FIGS. 30A-30B includes an annular atrial skirt or flange 514.
  • the atrial flange 514 may be an extension of the barrier 517 in the radial or generally radial direction for at least about 2 mm, or about 5 mm, or more.
  • the atrial flange 514 extends outward from a proximal edge of the outer frame 512.
  • the atrial flange 514 may instead extend outward from a distal edge of the outer frame 512, for example forming a "ventricular" flange situated inside the annulus and/or within the left ventricle (for a mitral valve implant).
  • Such "ventricular" flange may be analogous to the atrial flange 514 as described herein.
  • the atrial flange 514 and/or other flanges may further reduce and/or prevent of leakage of blood flow around the replacement valve implant 500, e.g. leakage in between the replacement valve implant 500and the surrounding valve annulus.
  • the atrial flange 514 may be a variety of suitable materials, such as ePTFE or a polyester material, for example Dacron.
  • the atrial flange 514 may thus be a similar material as the outer barrier 517.
  • the atrial flange 514 may also include an extension of the outer frame 512 in the outward direction and providing support for the barrier material, such as the polyester material.
  • FIG. 30B shows the replacement valve implant 500 in its deployed and anchored state.
  • the anchors 516 have been advanced through and engage the frame 508 and through the flange 514 and into tissue. Holes 503 are provided in or adjacent to the atrial flange 514 to allow the helically wound anchors 516 to pass therethrough and anchor into the annular tissue above the heart valve.
  • the anchors 516 may also fixedly engage the flange 514.
  • the anchors 516 may engage the atrial flange 514 such that a fixed connection is provided between the flange 514 and the respective anchor 516 before and/or after advancement of the anchors 516 therethrough.
  • the flange 514 has a generally annular shape around the circumference of the implant 500.
  • the flange 514 may be generally circular, or other rounded or non-rounded shapes.
  • the flange 514 maybe symmetric or asymmetric with respect to the axis or with a plane that includes the axis
  • the replacement valve implant 500 may have a variety of suitable dimensions.
  • the valve housing 510 In the deployed and anchored state, and/or the deployed and unanchored state, and/or in the anchored and uncinched state, and/or in the anchored and cinched state, the valve housing 510 may have a height measured along the axis 513 in the range of about twenty millimeters to about thirty millimeters, although such height can vary. In some embodiments, in these various states the valve housing 510 may have a height in the range of about ten millimeters to about fifty millimeters. Referring to FIGS. 30A-30B , the inner diameter 511 of the valve housing 510 may be within the range of about twenty-five millimeters to about thirty millimeters, although such diameter can be varied.
  • the inner diameter 511 of the valve housing 510 may be within the range of about fifteen millimeters to about sixty millimeters.
  • the atrial flange 514 may have a radial width 515 between about five millimeters and about thirty millimeters. In some embodiments, the atrial flange 514 may have a width 515 between about ten millimeters and about twenty millimeters wide.
  • the cinch frame 512 can have an outer diameter 523 from about forty millimeters to about eighty millimeters.
  • the inner diameter 525 of the cinch frame 512 which may be measured in some embodiments from anchor 516 head to opposite anchor 516 head, may range from about thirty millimeters to about sixty millimeters, or in some embodiments from about fifteen millimeters to about one hundred millimeters, in the cinched orientation.
  • the replacement valve implant 500 may encourage tissue ingrowth after implantation.
  • the inner our outer frame 508, 512, the inner barrier 519, the outer barrier 517, other features of the implant 500, or combinations thereof, may be configured to facilitate tissue ingrowth and further securement of the implant 500 within the heart.
  • FIG. 31 illustrates the replacement valve implant 500 positioned, anchored, cinched and implanted in the annular tissue above and proximate the target heart valve.
  • the replacement valve implant 500 has been deployed across the native mitral valve, with the atrial flange 514 blocking or at least substantially blocking paravalvular leakage around the replacement valve implant 500.
  • the replacement valve implant 500 is in sealing engagement with the atrial wall surrounding the native valve, which in some embodiments may be due in part to atrial blood pressure.
  • FIGS. 32A and 32B are perspective views of embodiments of heart valve replacements 520 and 520' without the additional sealing or atrial flange 514 and shown, respectively, in an unconstrained state and in a cinched state.
  • the heart valve replacement 520 includes the outer barrier 517 located on the outside of the outer frame 512
  • the heart valve replacement 520' includes the outer barrier 517 located on the inside of the outer frame 512.
  • the heart valve replacements 520 and 520' may otherwise be analogous to the heart valve replacement 500.
  • Like reference numerals with respect to FIGS. 30A through 30C thus represent like elements in FIGS. 32A and 32B .
  • the collars are actuated, in a manner similar to that of FIG. 30C , to cinch the replacement valve 520 as shown in FIG. 32B .
  • nine anchors 516 have been shown with respect to the replacement valve embodiments of FIGS. 30 through 32 , it is understood that the number of such anchors 516 can be varied. In some embodiments, such variance of the number of anchors 516 can range from three to eighteen. In some embodiments, the number of anchors 516 can vary in multiples of three.
  • FIGS. 33A and 33B Another embodiment of a replacement valve implant 530 is depicted in FIGS. 33A and 33B .
  • FIG. 33A shows the replacement valve implant 530 in an unconstrained and unanchored state
  • FIG. 33B shows the replacement valve implant 530 in an anchored, cinched and locked state.
  • the replacement valve implant 530 may include features analogous to features described with respect to other implants herein, for example the implant 1, 500, 520, 520', etc.
  • the replacement valve implant 530 includes an inner valve housing 532 and an outer frame 536.
  • the valve housing 532 may be analogous to the valve housing 510.
  • the valve housing 532 may include one or more leaflets 502, which may be analogous to the leaflets 502 as described with respect to the replacement valve implant 500.
  • the valve housing 532 may include an inner frame 535 as shown, which may be formed of nitinol.
  • the inner frame 535 may thus have proximal, generally diamond-shaped segments that are adjacent distal, irregular hexagonal-shaped segments extending circumferentially in a generally tubular shape about an axis, as indicated in FIG. 33B .
  • the valve housing 532 has a series of upper crowns 542 with openings therethrough. The openings may be circular or other shapes.
  • the openings in the upper crowns 542 may engage with one or more features of an outer cinch frame 536, such as extensions 540 that extend from upper crowns of the outer frame 536.
  • the outer frame 536 may be analogous to other frames or outer frames described herein, for example, the frames 10, 512, etc.
  • the outer frame 536 is coupled with one or more anchors 516 and one or more restraints such as collars 518.
  • the outer frame 536 may be coupled with the valve housing 532, for example the inner frame 535, at the upper (proximal) crowns 542, as described.
  • the outer frame 536 may be coupled with the inner frame 535 in other manners, such as at lower crowns, etc.
  • the inner and outer frames 535, 536 may be part of the same monolithic material, for example different portions of a single, continuous frame, etc.
  • the outer frame 536 may compress for delivery within a delivery catheter, expand upon deployment from the catheter, and contract upon advancement of collars 518, as described herein.
  • the outer frame 536 in an unconstrained state, as shown in FIG. 33A inclines radially outward in a distal direction from a proximal end of the valve housing 532. Contraction of the outer frame 536 to a cinched state, as shown in FIG. 33B , may resize and/or re-shape the native valve annulus.
  • the outer frame 536 may advance radially inwardly toward the axis to reduce the inner diameter of the native valve annulus into conformance with the inner frame 535.
  • the outer frame 536 may include collars 538 at the upper crowns 534.
  • the collars 538 may be advanced distally to cinch the implant 530 to cause the outer frame 536 to advance radially inward.
  • the collars 538 may interact with the outer frame 536 to cinch the outer frame 536 as described herein with respect to other collars and frames, such as the collars 18 and the frame 10, etc.
  • the extensions 540 include perpendicularly disposed tabs generally forming T-Bar extensions on the upper crowns 534 of the outer frame 536.
  • the extensions 540 engage with the openings in the upper crowns 542 of the valve housing 532 to pivotally secure the outer frame 536 to the valve housing 532.
  • the extensions 540 may be inserted into the openings during assembly of the replacement valve implant 530.
  • the anchors 516 are moveably engaged with lower crowns 521 that are located in between upper crowns 542 of the valve housing 532.
  • the anchors 516 may engage with the lower crowns as described herein with respect to other anchors and crowns, such as the anchors 20 and lower crowns 16, etc.
  • valve housing 532 may be tapered, for example having a smaller diameter on the atrial side of the valve orifice and a larger diameter on the ventricular side to facilitate blood flow through and across the replacement heart valve 530.
  • FIGS. 34A through 37 show various embodiments of sections of steerable catheters that may be used with the various implants described herein. The features of the steerable catheters improve the catheter's ability to maneuver tight bends to a position above and proximate and/or into the mitral valve annulus or tricuspid valve annulus.
  • FIGS. 34A and 34B are side views of an embodiment of a distal section 600 of a steerable catheter 602 shown in straight and flexed states, respectively, that may be used to deliver the various implants described herein.
  • the steerable catheter 602 may be used in the various delivery systems and methods described herein.
  • the steerable catheter 602 has a distal end 604 and intermediate section 606.
  • the distal end 604 may be a deflectable section, as described herein.
  • the distal end 604 may include a length of the catheter 602 extending from the distal tip.
  • the deflectable section of the distal end 604 may include a length of five or ten or fifteen centimeters, or more or less, of the catheter 602 as measured from the distal tip in a proximal direction.
  • the intermediate section 606 may take the form of a shaft section reinforced with a braid or slotted tubing.
  • the catheter 602 may include a proximal end opposite the distal end 604. Only a portion of the catheter 602 is shown for clarity.
  • the proximal end of the catheter 602 may be coupled with a proximal manifold having a deflection control.
  • the catheter 602 and/or features thereof may be implemented with the various catheters and delivery systems described herein, for example those shown in and/or described with respect to FIGS. 22A-25E , or others.
  • FIGS. 35A and 35B depict an embodiment of the distal section 604 that may be used with the steerable catheter 602, shown in straight and flexed states, respectively.
  • the distal section 604 has a single spine 608 running along its outer curve, and a series of support ribs 610 formed or cut into the inner curve.
  • the distal section 604 may be formed of a flexible metal tube, such as nitinol.
  • the distal section 604 may incorporate pull wires for control of the delivery system. Alternatively, the pull wire may be looped around the distal section's distal tip and back toward the proximal part of the catheter 602.
  • This flexed state of the distal section 604 is realized with minimal protrusion of the support ribs 610 into the inner diameter or outer diameter of the distal section 604.
  • the spine 608 provides a smooth surface on the outer curve of the distal section 604 minimizing friction or interference with heart tissue during delivery and positioning of the catheter and implant.
  • FIGS. 36A and 36B illustrate another embodiment of a distal section 614 that may be used with the steerable catheter 602.
  • the distal section 614 may be a flexible metal tube that is wrapped or encased in a thin film 612 or polymeric material such as Teflon, pTfe, nylon or other thin material.
  • This thin film 612 encapsulation does not restrict the flexibility of the distal section 614 but does provide for smoother delivery and transition into and out of a guide catheter.
  • the thin film 612 may be stretchable or designed to fold in on itself, somewhat similar to an accordion, when flexed as shown in FIG. 36B .
  • FIG. 37 shows another embodiment of a distal section 624 that may be used with the steerable catheter 602.
  • distal section 624 comprises a series of larger elements 626 and smaller elements 628.
  • the smaller elements 628 nest within the larger elements 626. All elements may slide over one another.
  • the metal elements are most overlapped.
  • the distal section 624 is actuated towards the flexed state, as shown for example in FIG. 37 , there may be progressively less overlap of the elements particularly on the outer curve of the distal section 624.
  • the embodiments of the distal and intermediate sections of the catheter 602 are intended for use in the delivery and implant of both the ring-like embodiments and the replacement valve embodiments described herein.
  • the catheter In treating the mitral valve, for example, once the catheter is passed through the septum separating the right and left atria, it is guided slightly upwardly towards the upper reaches of the left atrial chamber. It is then bent significantly in a direction downward towards the mitral annulus, aligning the distal end and the implant with the mitral annulus.
  • the devices, systems and methods described herein allow such bending to occur without kinking or wrinkling which would otherwise impede delivery of the implant.

Claims (15)

  1. Implant pour réduire une régurgitation de valvule cardiaque comprenant :
    un cadre (100, 101, 102) ayant des couronnes supérieures (14, 114, 124, 144), des couronnes inférieures (16, 116) et des entretoises (12, 112) entre les couronnes supérieures et inférieures, le cadre (100, 101, 102) ayant une configuration d'entrée en prise avec du tissu ayant un diamètre d'entrée en prise avec du tissu et une configuration de remodelage d'anneau où le cadre (100, 101, 102) a un diamètre de remodelage d'anneau qui est inférieur au diamètre d'entrée en prise avec du tissu ;
    une pluralité d'éléments d'ancrage (20, 120) accouplés aux couronnes inférieures (16, 116) du cadre (100, 101, 102) pour entrer en prise avec un tissu cardiaque à proximité de l'anneau de valvule cardiaque ; et
    une pluralité de colliers (18, 90, 118, 128, 148) accouplés aux couronnes supérieures (14, 114, 124, 144) du cadre (100, 101, 102), dans lequel lorsqu'une force est appliquée aux colliers (18, 90, 118, 128, 148), les colliers (18, 90, 118, 128, 148) glissent le long des couronnes supérieures (14, 114, 124, 144) et des entretoises (12, 112) pour déplacer le cadre (100, 101, 102) de la configuration d'entrée en prise avec du tissu vers la configuration de remodelage d'anneau, caractérisé en ce que les couronnes inférieures (16, 116) sont inclinées selon un angle par rapport aux entretoises (12, 112).
  2. Implant selon la revendication 1, dans lequel la pluralité d'éléments d'ancrage (20, 120) sont des éléments d'ancrage enroulés en hélice (20, 120) et les couronnes inférieures (16, 116) du cadre (100, 101, 102) sont conçues pour recevoir par filetage les éléments d'ancrage enroulés en hélice (20, 120).
  3. Implant selon la revendication 2, dans lequel les éléments d'ancrage enroulés en hélice (20, 120) comprennent en outre des têtes d'ancrage (22) destinées à entrer en prise avec des actionneurs pour faire avancer en rotation les éléments d'ancrage enroulés en hélice (20, 120) dans le tissu cardiaque afin d'ancrer le cadre (100, 101, 102) dans le tissu cardiaque.
  4. Implant selon la revendication 3, comprenant en outre des butées (24) sur chacune des têtes d'ancrage (22) pour entrer en prise avec les entretoises (12, 112) et les couronnes inférieures (16, 116) pour limiter le déplacement des éléments d'ancrage enroulés en hélice (20, 120).
  5. Implant selon l'une quelconque des revendications 2 à 4, dans lequel les éléments d'ancrage enroulés en hélice (20, 120) ont des pointes aiguisées pour faciliter la pénétration des éléments d'ancrage enroulés en hélice (20, 120) dans le tissu cardiaque.
  6. Implant selon l'une quelconque des revendications 1 à 4, comprenant en outre au moins une languette (19, 92, 149) sur chacun des colliers (18, 90, 118, 128, 148), dans lequel les languettes (19, 92, 149) sont sollicitées vers l'intérieur pour entrer en prise avec les couronnes supérieures (14, 114, 124) lorsque les colliers (18, 90, 118, 128, 148) sont glissés sur les couronnes supérieures (14, 114, 124, 144) et les entretoises (12, 112).
  7. Implant selon l'une quelconque des revendications 1 à 4, comprenant en outre une rainure (150) formée sur un côté tourné vers l'extérieur des couronnes supérieures (14, 114, 124, 144) et au moins une languette (19, 92, 149) sur chacun des colliers (18, 90, 118, 128, 148), dans lequel les languettes (19, 92, 149) sont sollicitées vers l'intérieur pour entrer en prise avec la rainure (150).
  8. Implant selon l'une quelconque des revendications 1 à 4, comprenant en outre des sections flexibles (78, 88) sur les colliers (18, 90, 118, 128, 148) pour faciliter l'avancement des colliers (18, 90, 118, 128, 148) sur les couronnes supérieures (14, 114, 124, 144) et les entretoises (12, 112).
  9. Implant selon l'une quelconque des revendications 1 à 4, dans lequel le cadre (100, 101, 102) définit un axe longitudinal, et dans lequel les couronnes inférieures (16, 116) et les éléments d'ancrage (20, 120) reçus dans les couronnes inférieures (16, 116) sont inclinés vers l'extérieur dans une direction distale selon un angle entre environ 30° et environ 60° par rapport à une partie de l'axe qui s'étend distalement sous l'implant.
  10. Système de pose pour poser un implant pour réduire une régurgitation de valvule cardiaque, le système de pose comprenant :
    l'implant selon l'une quelconque des revendications précédentes ;
    un cathéter de pose (40) fixé de manière libérable à l'implant et conçu pour poser l'implant en une position proche de l'anneau de valvule cardiaque ; et
    un cathéter d'imagerie (270, 300) comprenant une extrémité distale conçue pour s'étendre à proximité de l'anneau de valvule cardiaque et pour capturer une ou plusieurs images en son sein de la position de l'implant par rapport à l'anneau de valvule cardiaque.
  11. Système de pose selon la revendication 10, comprenant en outre une pluralité d'éléments d'actionnement (22') destinés à entrer en prise avec des éléments d'ancrage (20, 120) correspondants de l'implant pour amener les éléments d'ancrage (20, 120) à pénétrer et à avancer dans le tissu cardiaque afin d'ancrer le cadre (100, 101, 102) en position à proximité de l'anneau de valvule cardiaque.
  12. Système de pose selon l'une quelconque des revendications 10, comprenant en outre une pluralité d'éléments pousseurs (56) pour entrer en prise avec des colliers (18, 90, 118, 128, 148) correspondants de l'implant pour faire avancer de force chaque collier (18, 90, 118, 128, 148) sur sa couronne supérieure respective (14, 114, 124, 144) et ses entretoises (12, 112), réduisant de ce fait le diamètre du cadre (100, 101, 102) et de l'anneau de valvule.
  13. Système de pose selon l'une quelconque des revendications 10 à 12, comprenant en outre des moyens pour centrer (280) le cathéter d'imagerie (270, 300) par rapport à l'implant.
  14. Système de pose selon l'une quelconque des revendications 10 à 12, dans lequel l'extrémité distale du cathéter d'imagerie (270, 300) comprend des transducteurs à ultrasons (302, 304) disposés longitudinalement et circonférentiellement.
  15. Système de pose selon les revendications 10 à 14, comprenant en outre :
    une boucle (320) encerclant le cadre (100, 101, 102) à proximité de ses couronnes inférieures (16, 116) ; et
    un actionneur de resserrement (330) pour resserrer la boucle (320) afin de faciliter l'affaissement et le chargement de l'implant dans le système de pose.
EP16804980.7A 2015-11-17 2016-11-15 Dispositif implantable et système de mise en place pour remodeler un anneau de valve cardiaque Active EP3377000B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562256660P 2015-11-17 2015-11-17
PCT/US2016/062107 WO2017087424A1 (fr) 2015-11-17 2016-11-15 Dispositif implantable et système de mise en place pour remodeler un anneau de valve cardiaque

Publications (2)

Publication Number Publication Date
EP3377000A1 EP3377000A1 (fr) 2018-09-26
EP3377000B1 true EP3377000B1 (fr) 2023-02-01

Family

ID=57442826

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16804980.7A Active EP3377000B1 (fr) 2015-11-17 2016-11-15 Dispositif implantable et système de mise en place pour remodeler un anneau de valve cardiaque

Country Status (6)

Country Link
US (3) US10555813B2 (fr)
EP (1) EP3377000B1 (fr)
JP (2) JP6892446B2 (fr)
CN (2) CN108289737B (fr)
IL (1) IL259333A (fr)
WO (1) WO2017087424A1 (fr)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8870950B2 (en) 2009-12-08 2014-10-28 Mitral Tech Ltd. Rotation-based anchoring of an implant
US20110224785A1 (en) 2010-03-10 2011-09-15 Hacohen Gil Prosthetic mitral valve with tissue anchors
US11653910B2 (en) 2010-07-21 2023-05-23 Cardiovalve Ltd. Helical anchor implantation
US9763657B2 (en) 2010-07-21 2017-09-19 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
US8845717B2 (en) 2011-01-28 2014-09-30 Middle Park Medical, Inc. Coaptation enhancement implant, system, and method
US8888843B2 (en) 2011-01-28 2014-11-18 Middle Peak Medical, Inc. Device, system, and method for transcatheter treatment of valve regurgitation
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
WO2013021375A2 (fr) 2011-08-05 2013-02-14 Mitraltech Ltd. Remplacement et fixation percutanés d'une valvule mitrale
WO2013021374A2 (fr) * 2011-08-05 2013-02-14 Mitraltech Ltd. Techniques pour le remplacement et la fixation percutanés d'une valvule mitrale
US20150351906A1 (en) 2013-01-24 2015-12-10 Mitraltech Ltd. Ventricularly-anchored prosthetic valves
US10166098B2 (en) 2013-10-25 2019-01-01 Middle Peak Medical, Inc. Systems and methods for transcatheter treatment of valve regurgitation
EP3160396B1 (fr) 2014-06-24 2022-03-23 Polares Medical Inc. Systèmes d'ancrage d'un implant
WO2016016899A1 (fr) 2014-07-30 2016-02-04 Mitraltech Ltd. Prothèse valvulaire articulable
US10080660B2 (en) * 2014-12-19 2018-09-25 Paradox Medical Limited Implantable intracardiac device and methods thereof
US9974651B2 (en) 2015-02-05 2018-05-22 Mitral Tech Ltd. Prosthetic valve with axially-sliding frames
WO2016125160A1 (fr) 2015-02-05 2016-08-11 Mitraltech Ltd. Valve prothétique avec cadres coulissant axialement
US9592121B1 (en) 2015-11-06 2017-03-14 Middle Peak Medical, Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
CN108289737B (zh) * 2015-11-17 2020-03-31 魅尔皮德股份有限公司 用于使心脏瓣环重新定形的可植入装置和输送系统
US11833034B2 (en) 2016-01-13 2023-12-05 Shifamed Holdings, Llc Prosthetic cardiac valve devices, systems, and methods
US10531866B2 (en) 2016-02-16 2020-01-14 Cardiovalve Ltd. Techniques for providing a replacement valve and transseptal communication
US20200146854A1 (en) * 2016-05-16 2020-05-14 Elixir Medical Corporation Methods and devices for heart valve repair
US11504064B2 (en) * 2016-07-28 2022-11-22 Evalve, Inc. Systems and methods for intra-procedural cardiac pressure monitoring
GB201613219D0 (en) 2016-08-01 2016-09-14 Mitraltech Ltd Minimally-invasive delivery systems
CN109789018B (zh) 2016-08-10 2022-04-26 卡迪尔维尔福股份有限公司 具有同轴框架的人工瓣膜
US10758348B2 (en) * 2016-11-02 2020-09-01 Edwards Lifesciences Corporation Supra and sub-annular mitral valve delivery system
EP3579789A4 (fr) * 2017-02-10 2020-09-30 Millipede, Inc. Dispositif implantable et système de mise en place permettant de remodeler un anneau de valvule cardiaque
US10478303B2 (en) 2017-03-13 2019-11-19 Polares Medical Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
US10653524B2 (en) 2017-03-13 2020-05-19 Polares Medical Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
US11793633B2 (en) 2017-08-03 2023-10-24 Cardiovalve Ltd. Prosthetic heart valve
US11304805B2 (en) 2017-09-19 2022-04-19 Cardiovalve Ltd. Prosthetic valve with inflatable cuff configured to fill a volume between atrial and ventricular tissue anchors
US11246704B2 (en) 2017-08-03 2022-02-15 Cardiovalve Ltd. Prosthetic heart valve
US10888421B2 (en) 2017-09-19 2021-01-12 Cardiovalve Ltd. Prosthetic heart valve with pouch
CN111263622A (zh) 2017-08-25 2020-06-09 内奥瓦斯克迪亚拉公司 顺序展开的经导管二尖瓣假体
US9895226B1 (en) 2017-10-19 2018-02-20 Mitral Tech Ltd. Techniques for use with prosthetic valve leaflets
GB201720803D0 (en) 2017-12-13 2018-01-24 Mitraltech Ltd Prosthetic Valve and delivery tool therefor
GB201800399D0 (en) 2018-01-10 2018-02-21 Mitraltech Ltd Temperature-control during crimping of an implant
EP3823557A1 (fr) 2018-07-18 2021-05-26 Boston Scientific Scimed, Inc. Système de retenue de déploiement et de pose pour dispositif cardiaque implantable
US10779946B2 (en) 2018-09-17 2020-09-22 Cardiovalve Ltd. Leaflet-testing apparatus
EP3860519A4 (fr) 2018-10-05 2022-07-06 Shifamed Holdings, LLC Dispositifs, systèmes et méthodes pour valvule cardiaque prothétique
EP3870111A1 (fr) * 2018-10-22 2021-09-01 Boston Scientific Scimed Inc. Système de distribution avec retenue centrale intégrée pour un dispositif cardiaque implantable
US11737872B2 (en) 2018-11-08 2023-08-29 Neovasc Tiara Inc. Ventricular deployment of a transcatheter mitral valve prosthesis
US11471282B2 (en) 2019-03-19 2022-10-18 Shifamed Holdings, Llc Prosthetic cardiac valve devices, systems, and methods
AU2020256195B2 (en) 2019-04-01 2022-10-13 Neovasc Tiara Inc. Controllably deployable prosthetic valve
CA3140925A1 (fr) 2019-05-20 2020-11-26 Neovasc Tiara Inc. Dispositif d'introduction avec mecanisme d'hemostase
JP7315708B2 (ja) * 2019-06-07 2023-07-26 ボストン サイエンティフィック サイムド，インコーポレイテッド 弁輪を再形成するためのシステム、装置及び方法
EP3986332A4 (fr) 2019-06-20 2023-07-19 Neovasc Tiara Inc. Valve mitrale prothétique à profil bas
JP7357083B2 (ja) * 2019-06-28 2023-10-05 ボストン サイエンティフィック サイムド，インコーポレイテッド 弁輪形成術のための手動内部ガイドワイヤナビゲーション
US11523906B2 (en) 2019-07-01 2022-12-13 Boston Scientific Scimed, Inc. Detachable sliding actuators for valve repair devices
JP7351940B2 (ja) * 2019-07-09 2023-09-27 ボストン サイエンティフィック サイムド，インコーポレイテッド 心血管装置用歪み緩和スリーブ
JP2022534251A (ja) * 2019-08-05 2022-07-28 ボストン サイエンティフィック サイムド，インコーポレイテッド 弁修復装置のフレーム解放機構
US20220331106A1 (en) * 2019-08-21 2022-10-20 Boston Scientific Scimed, Inc. Anchor designs with adaptable length control
WO2021050466A1 (fr) 2019-09-10 2021-03-18 Boston Scientific Scimed, Inc. Ancrage réversible à auto-verrouillage par ressort
US11678987B2 (en) 2019-12-03 2023-06-20 Boston Scientific Scimed, Inc. Coil and barb anchors for heart valve repair devices
CA3166714A1 (fr) * 2020-01-10 2021-07-15 Edwards Lifesciences Innovation (Israel) Ltd. Dispositifs ultrasonores pour catheter et procedes d'evaluation de tissu biologique cible
CN115151221A (zh) * 2020-01-14 2022-10-04 爱德华兹生命科学公司 可机械扩展瓣膜的扩展和锁定机构
EP4093331A1 (fr) 2020-01-21 2022-11-30 Boston Scientific Scimed, Inc. Cadre de ruban à profil bas pour dispositifs de réparation de valve
WO2021150329A1 (fr) 2020-01-22 2021-07-29 Boston Scientific Scimed, Inc. Système d'administration simplifié de conception d'arbre coaxial et implant pour réduction d'anneau de valvule mitrale
US11642221B2 (en) 2020-01-28 2023-05-09 Boston Scientific Scimed, Inc. Implantable device having rounded struts and method of manufacture
WO2022060713A1 (fr) 2020-09-17 2022-03-24 Boston Scientific Scimed, Inc. Patch annulaire prédisposé pour implant de réparation de valvule
US20220096258A1 (en) 2020-09-25 2022-03-31 Boston Scientific Scimed, Inc. Latch wire and driver shaft
JP2023539191A (ja) 2020-09-25 2023-09-13 ボストン サイエンティフィック サイムド，インコーポレイテッド 移動を最小にして係合を最大にする組織アンカー
CN116583231A (zh) * 2020-12-10 2023-08-11 波士顿科学国际有限公司 用于可植入装置的锚固装置、系统和方法
US11464634B2 (en) 2020-12-16 2022-10-11 Polares Medical Inc. Device, system, and method for transcatheter treatment of valvular regurgitation with secondary anchors
WO2022133088A1 (fr) 2020-12-17 2022-06-23 Boston Scientific Scimed, Inc. Dispositifs implants, systèmes et méthodes de réduction d'anneau
WO2022140189A1 (fr) 2020-12-22 2022-06-30 Boston Scientific Scimed, Inc. Composants non traumatiques pour dispositif de réduction de l'espace annulaire
WO2022166064A1 (fr) * 2021-02-05 2022-08-11 上海臻亿医疗科技有限公司 Dispositif de valve implantable
CN117157033A (zh) * 2021-02-09 2023-12-01 爱德华兹生命科学创新(以色列)有限公司 用于心脏瓣膜修复的系统和设备
EP4312804A1 (fr) * 2021-03-25 2024-02-07 Edwards Lifesciences Innovation (Israel) Ltd. Implants de contraction de tissu pour valvules cardiaques
WO2022249062A1 (fr) * 2021-05-25 2022-12-01 Medtronic, Inc. Méthodes et systèmes de réparation d'anneau
US11759321B2 (en) 2021-06-25 2023-09-19 Polares Medical Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
WO2023287493A1 (fr) 2021-07-13 2023-01-19 Boston Scientific Scimed, Inc. Systèmes de déploiement d'un dispositif médical implantable
WO2023049100A1 (fr) 2021-09-24 2023-03-30 Boston Scientific Scimed, Inc. Dispositifs et systèmes pour ajuster la position d'un élément implantable
CN116712214A (zh) * 2022-03-07 2023-09-08 宁波健世科技股份有限公司 用于修复瓣膜的成形术装置

Family Cites Families (282)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3143742A (en) 1963-03-19 1964-08-11 Surgitool Inc Prosthetic sutureless heart valve
DE3230858C2 (de) 1982-08-19 1985-01-24 Ahmadi, Ali, Dr. med., 7809 Denzlingen Ringprothese
FR2587614B1 (fr) 1985-09-23 1988-01-15 Biomasys Sa Valve cardiaque prothetique
EP0457842B1 (fr) 1989-02-13 1994-07-20 Baxter International Inc. Anneau d'annuloplastie selectivement flexible
US5674280A (en) 1989-12-21 1997-10-07 Smith & Nephew, Inc. Valvular annuloplasty rings of a biocompatible low elastic modulus titanium-niobium-zirconium alloy
US5370685A (en) 1991-07-16 1994-12-06 Stanford Surgical Technologies, Inc. Endovascular aortic valve replacement
EP0624080B1 (fr) 1992-01-27 2001-12-12 Medtronic, Inc. Anneaux d'annuloplastie et de suture
US5234448A (en) 1992-02-28 1993-08-10 Shadyside Hospital Method and apparatus for connecting and closing severed blood vessels
US5772590A (en) 1992-06-30 1998-06-30 Cordis Webster, Inc. Cardiovascular catheter with laterally stable basket-shaped electrode array with puller wire
US5582616A (en) 1994-08-05 1996-12-10 Origin Medsystems, Inc. Surgical helical fastener with applicator
US5716399A (en) 1995-10-06 1998-02-10 Cardiomend Llc Methods of heart valve repair
US5769816A (en) 1995-11-07 1998-06-23 Embol-X, Inc. Cannula with associated filter
US5662704A (en) 1995-12-01 1997-09-02 Medtronic, Inc. Physiologic mitral valve bioprosthesis
WO1997019655A1 (fr) 1995-12-01 1997-06-05 Medtronic, Inc. Prothese pour annuloplastie
US6402780B2 (en) 1996-02-23 2002-06-11 Cardiovascular Technologies, L.L.C. Means and method of replacing a heart valve in a minimally invasive manner
US5716397A (en) 1996-12-06 1998-02-10 Medtronic, Inc. Annuloplasty device with removable stiffening element
US5968053A (en) 1997-01-31 1999-10-19 Cardiac Assist Technologies, Inc. Method and apparatus for implanting a graft in a vessel of a patient
US5984959A (en) 1997-09-19 1999-11-16 United States Surgical Heart valve replacement tools and procedures
US6174332B1 (en) 1997-12-05 2001-01-16 St. Jude Medical, Inc. Annuloplasty ring with cut zone
US6254642B1 (en) 1997-12-09 2001-07-03 Thomas V. Taylor Perorally insertable gastroesophageal anti-reflux valve prosthesis and tool for implantation thereof
US6332893B1 (en) 1997-12-17 2001-12-25 Myocor, Inc. Valve to myocardium tension members device and method
US6001127A (en) 1998-03-31 1999-12-14 St. Jude Medical, Inc. Annuloplasty ring holder
US6776791B1 (en) 1998-04-01 2004-08-17 Endovascular Technologies, Inc. Stent and method and device for packing of same
US6176877B1 (en) 1998-04-20 2001-01-23 St. Jude Medical, Inc. Two piece prosthetic heart valve
US6074418A (en) 1998-04-20 2000-06-13 St. Jude Medical, Inc. Driver tool for heart valve prosthesis fasteners
US7722667B1 (en) 1998-04-20 2010-05-25 St. Jude Medical, Inc. Two piece bioprosthetic heart valve with matching outer frame and inner valve
US6306163B1 (en) 1998-08-04 2001-10-23 Advanced Cardiovascular Systems, Inc. Assembly for collecting emboli and method of use
US6059731A (en) * 1998-08-19 2000-05-09 Mayo Foundation For Medical Education And Research Simultaneous side-and-end viewing underfluid catheter
US6355030B1 (en) 1998-09-25 2002-03-12 Cardiothoracic Systems, Inc. Instruments and methods employing thermal energy for the repair and replacement of cardiac valves
US6334873B1 (en) 1998-09-28 2002-01-01 Autogenics Heart valve having tissue retention with anchors and an outer sheath
US6231602B1 (en) 1999-04-16 2001-05-15 Edwards Lifesciences Corporation Aortic annuloplasty ring
US6428550B1 (en) 1999-05-18 2002-08-06 Cardica, Inc. Sutureless closure and deployment system for connecting blood vessels
US6790229B1 (en) 1999-05-25 2004-09-14 Eric Berreklouw Fixing device, in particular for fixing to vascular wall tissue
US20050192629A1 (en) 1999-06-25 2005-09-01 Usgi Medical Inc. Methods and apparatus for creating and regulating a gastric stoma
SE514718C2 (sv) 1999-06-29 2001-04-09 Jan Otto Solem Anordning för behandling av bristande tillslutningsförmåga hos mitralisklaffapparaten
US7192442B2 (en) 1999-06-30 2007-03-20 Edwards Lifesciences Ag Method and device for treatment of mitral insufficiency
US20060212114A1 (en) 1999-07-26 2006-09-21 Chase Medical, L.P. Devices and methods for mitral valve annulus reformation
US7674222B2 (en) 1999-08-09 2010-03-09 Cardiokinetix, Inc. Cardiac device and methods of use thereof
US6485489B2 (en) 1999-10-02 2002-11-26 Quantum Cor, Inc. Catheter system for repairing a mitral valve annulus
US6682540B1 (en) * 1999-11-05 2004-01-27 Onux Medical, Inc. Apparatus and method for placing multiple sutures
US6736829B1 (en) 1999-11-11 2004-05-18 Linvatec Corporation Toggle anchor and tool for insertion thereof
US8579966B2 (en) 1999-11-17 2013-11-12 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US8016877B2 (en) 1999-11-17 2011-09-13 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US20070043435A1 (en) * 1999-11-17 2007-02-22 Jacques Seguin Non-cylindrical prosthetic valve system for transluminal delivery
US7018406B2 (en) 1999-11-17 2006-03-28 Corevalve Sa Prosthetic valve for transluminal delivery
WO2001050985A1 (fr) 2000-01-14 2001-07-19 Viacor Incorporated Bande tissulaire pour annuloplastie et dispositif et procede permettant de modeler, de tailler et d'implanter une telle bande
US6989028B2 (en) 2000-01-31 2006-01-24 Edwards Lifesciences Ag Medical system and method for remodeling an extravascular tissue structure
US7296577B2 (en) 2000-01-31 2007-11-20 Edwards Lifescience Ag Transluminal mitral annuloplasty with active anchoring
US20050070999A1 (en) 2000-02-02 2005-03-31 Spence Paul A. Heart valve repair apparatus and methods
US6797002B2 (en) 2000-02-02 2004-09-28 Paul A. Spence Heart valve repair apparatus and methods
US20050267560A1 (en) 2000-02-03 2005-12-01 Cook Incorporated Implantable bioabsorbable valve support frame
DE10010073B4 (de) 2000-02-28 2005-12-22 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verankerung für implantierbare Herzklappenprothesen
US6454799B1 (en) 2000-04-06 2002-09-24 Edwards Lifesciences Corporation Minimally-invasive heart valves and methods of use
ITPC20000013A1 (it) 2000-04-13 2000-07-13 Paolo Ferrazzi Dispositivo endoventricolare e metodo relativo per il trattamento e la correzione di miocardiopatie.
US6485503B2 (en) 2000-05-19 2002-11-26 Coapt Systems, Inc. Multi-point tissue tension distribution device, a brow and face lift variation, and a method of tissue approximation using the device
US20040010275A1 (en) 2000-05-19 2004-01-15 Daniel Jacobs Multi-point tissue tension distribution device and method, a custom-fittable variation
US6869444B2 (en) 2000-05-22 2005-03-22 Shlomo Gabbay Low invasive implantable cardiac prosthesis and method for helping improve operation of a heart valve
US6743239B1 (en) 2000-05-25 2004-06-01 St. Jude Medical, Inc. Devices with a bendable tip for medical procedures
US6805711B2 (en) 2000-06-02 2004-10-19 3F Therapeutics, Inc. Expandable medical implant and percutaneous delivery
WO2002000099A2 (fr) 2000-06-23 2002-01-03 Viacor Incorporated Reparation de valvule mitrale par plication annulaire automatisee
US6695878B2 (en) 2000-06-26 2004-02-24 Rex Medical, L.P. Vascular device for valve leaflet apposition
US6419696B1 (en) 2000-07-06 2002-07-16 Paul A. Spence Annuloplasty devices and related heart valve repair methods
US20080091264A1 (en) 2002-11-26 2008-04-17 Ample Medical, Inc. Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools
US20090287179A1 (en) 2003-10-01 2009-11-19 Ample Medical, Inc. Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools
US8784482B2 (en) 2000-09-20 2014-07-22 Mvrx, Inc. Method of reshaping a heart valve annulus using an intravascular device
US8956407B2 (en) 2000-09-20 2015-02-17 Mvrx, Inc. Methods for reshaping a heart valve annulus using a tensioning implant
US7691144B2 (en) 2003-10-01 2010-04-06 Mvrx, Inc. Devices, systems, and methods for reshaping a heart valve annulus
CA2425009A1 (fr) 2000-10-19 2002-05-02 Thomas G. Schoon Outil entraineur avec plusieurs couches de pignons menants pour attaches d'une prothese cardiaque
US6913608B2 (en) 2000-10-23 2005-07-05 Viacor, Inc. Automated annular plication for mitral valve repair
US6582460B1 (en) 2000-11-20 2003-06-24 Advanced Cardiovascular Systems, Inc. System and method for accurately deploying a stent
US6974476B2 (en) 2003-05-05 2005-12-13 Rex Medical, L.P. Percutaneous aortic valve
AU2002243851A1 (en) 2001-02-05 2002-08-19 Viacor, Inc. Apparatus and method for reducing mitral regurgitation
WO2002096275A2 (fr) 2001-03-05 2002-12-05 Viacor, Incorporated Appareil et procede permettant de reduire la regurgitation mitrale
US6837901B2 (en) 2001-04-27 2005-01-04 Intek Technology L.L.C. Methods for delivering, repositioning and/or retrieving self-expanding stents
US7935145B2 (en) 2001-05-17 2011-05-03 Edwards Lifesciences Corporation Annuloplasty ring for ischemic mitral valve insuffuciency
US7087088B2 (en) 2001-05-24 2006-08-08 Torax Medical, Inc. Methods and apparatus for regulating the flow of matter through body tubing
US6726716B2 (en) 2001-08-24 2004-04-27 Edwards Lifesciences Corporation Self-molding annuloplasty ring
US20030050693A1 (en) 2001-09-10 2003-03-13 Quijano Rodolfo C. Minimally invasive delivery system for annuloplasty rings
US6824562B2 (en) 2002-05-08 2004-11-30 Cardiac Dimensions, Inc. Body lumen device anchor, device and assembly
US6805710B2 (en) 2001-11-13 2004-10-19 Edwards Lifesciences Corporation Mitral valve annuloplasty ring for molding left ventricle geometry
US20050177180A1 (en) 2001-11-28 2005-08-11 Aptus Endosystems, Inc. Devices, systems, and methods for supporting tissue and/or structures within a hollow body organ
US6652537B2 (en) 2001-12-12 2003-11-25 C. R. Bard, Inc. Articulating stone basket
JP4230915B2 (ja) 2001-12-21 2009-02-25 シムチャ ミロ 輪状形成リング用移植システム
US9204956B2 (en) 2002-02-20 2015-12-08 C. R. Bard, Inc. IVC filter with translating hooks
US20030225420A1 (en) 2002-03-11 2003-12-04 Wardle John L. Surgical coils and methods of deploying
US6752828B2 (en) 2002-04-03 2004-06-22 Scimed Life Systems, Inc. Artificial valve
US7007698B2 (en) 2002-04-03 2006-03-07 Boston Scientific Corporation Body lumen closure
US20030199974A1 (en) 2002-04-18 2003-10-23 Coalescent Surgical, Inc. Annuloplasty apparatus and methods
DE60325355D1 (de) 2002-06-04 2009-01-29 Abbott Vascular Inc Chirurgische klemme und anbringungsvorrichtung zur gefässwundverschliessung
US20040243227A1 (en) 2002-06-13 2004-12-02 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US8287555B2 (en) 2003-02-06 2012-10-16 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US6986775B2 (en) 2002-06-13 2006-01-17 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US20040067544A1 (en) 2002-06-27 2004-04-08 Viola Vogel Use of adhesion molecules as bond stress-enhanced nanoscale binding switches
US7559936B2 (en) 2002-08-13 2009-07-14 The General Hospital Corporation Cardiac devices and methods for percutaneous repair of atrioventricular valves
US8758372B2 (en) 2002-08-29 2014-06-24 St. Jude Medical, Cardiology Division, Inc. Implantable devices for controlling the size and shape of an anatomical structure or lumen
WO2007136783A2 (fr) 2002-08-29 2007-11-29 Mitralsolutions, Inc. Dispositfs implantables destinés à commander la taille et la forme d'une structure ou d'une lumière anatomique
US7455690B2 (en) 2002-08-29 2008-11-25 Mitralsolutions, Inc. Methods for controlling the internal circumference of an anatomic orifice or lumen
US6875231B2 (en) 2002-09-11 2005-04-05 3F Therapeutics, Inc. Percutaneously deliverable heart valve
DE10245519A1 (de) 2002-09-27 2004-04-08 Schenck Rotec Gmbh Unwuchtausgleichsstation für Fahrzeugräder
US7323004B2 (en) 2002-09-30 2008-01-29 Ethicon, Inc. Device for providing automatic stitching of an incision
US20040088003A1 (en) 2002-09-30 2004-05-06 Leung Jeffrey C. Barbed suture in combination with surgical needle
CN100553590C (zh) 2002-10-01 2009-10-28 安普尔医药公司 修整心瓣体环的装置
AU2003277118A1 (en) 2002-10-01 2004-04-23 Ample Medical, Inc. Devices for retaining native heart valve leaflet
FR2845590B1 (fr) 2002-10-10 2005-10-21 Jean Francois Garbe Dispositif de liaison entre une prothese et un conduit corporel et dispositif de connexion de deux conduits corporels disposes bout a bout
US7087064B1 (en) 2002-10-15 2006-08-08 Advanced Cardiovascular Systems, Inc. Apparatuses and methods for heart valve repair
US20050119735A1 (en) 2002-10-21 2005-06-02 Spence Paul A. Tissue fastening systems and methods utilizing magnetic guidance
US7247134B2 (en) 2002-11-12 2007-07-24 Myocor, Inc. Devices and methods for heart valve treatment
US7112219B2 (en) 2002-11-12 2006-09-26 Myocor, Inc. Devices and methods for heart valve treatment
US7485143B2 (en) 2002-11-15 2009-02-03 Abbott Cardiovascular Systems Inc. Apparatuses and methods for heart valve repair
US8187324B2 (en) 2002-11-15 2012-05-29 Advanced Cardiovascular Systems, Inc. Telescoping apparatus for delivering and adjusting a medical device in a vessel
US7404824B1 (en) 2002-11-15 2008-07-29 Advanced Cardiovascular Systems, Inc. Valve aptation assist device
US7335213B1 (en) 2002-11-15 2008-02-26 Abbott Cardiovascular Systems Inc. Apparatus and methods for heart valve repair
EP1560541A2 (fr) 2002-11-15 2005-08-10 Paracor Medical, Inc. Dispositif d'implantation de harnais de securite cardiaque
US8551162B2 (en) 2002-12-20 2013-10-08 Medtronic, Inc. Biologically implantable prosthesis
JP4691017B2 (ja) 2003-03-18 2011-06-01 セント ジュード メディカル インコーポレイテッド 体組織のリモデリング方法および装置
WO2004103223A1 (fr) 2003-05-20 2004-12-02 The Cleveland Clinic Foundation Appareil et procede pour reparer une valvule cardiaque
US6942641B2 (en) 2003-05-30 2005-09-13 J. Michael Seddon Catheter
US7887582B2 (en) 2003-06-05 2011-02-15 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US20040260394A1 (en) 2003-06-20 2004-12-23 Medtronic Vascular, Inc. Cardiac valve annulus compressor system
JP2007535335A (ja) 2003-06-20 2007-12-06 メドトロニック ヴァスキュラー インコーポレイテッド 弁輪の縮小システム
US20060184240A1 (en) 2003-06-25 2006-08-17 Georgia Tech Research Corporation Annuloplasty chain
US20050004665A1 (en) 2003-07-02 2005-01-06 Lishan Aklog Annuloplasty rings and methods for repairing cardiac valves
US8052751B2 (en) 2003-07-02 2011-11-08 Flexcor, Inc. Annuloplasty rings for repairing cardiac valves
WO2005007037A1 (fr) 2003-07-11 2005-01-27 Vedic Biotechnology, Inc. Annuloplastie selective pour regurgitation d'une valvule cardiaque auriculo-ventriculaire et dispositifs associes
US7160322B2 (en) 2003-08-13 2007-01-09 Shlomo Gabbay Implantable cardiac prosthesis for mitigating prolapse of a heart valve
US20050049692A1 (en) 2003-09-02 2005-03-03 Numamoto Michael J. Medical device for reduction of pressure effects of cardiac tricuspid valve regurgitation
US7534204B2 (en) * 2003-09-03 2009-05-19 Guided Delivery Systems, Inc. Cardiac visualization devices and methods
US20050075713A1 (en) 2003-10-06 2005-04-07 Brian Biancucci Minimally invasive valve replacement system
US7556647B2 (en) 2003-10-08 2009-07-07 Arbor Surgical Technologies, Inc. Attachment device and methods of using the same
US7004176B2 (en) 2003-10-17 2006-02-28 Edwards Lifesciences Ag Heart valve leaflet locator
JP2007510525A (ja) 2003-11-12 2007-04-26 メドトロニック ヴァスキュラー インコーポレイテッド 心臓弁輪縮小システム
WO2005055883A1 (fr) 2003-12-04 2005-06-23 The Brigham And Women's Hospital, Inc. Anneaux d'annuloplastie pour valvule aortique
US20050273138A1 (en) 2003-12-19 2005-12-08 Guided Delivery Systems, Inc. Devices and methods for anchoring tissue
US7166127B2 (en) 2003-12-23 2007-01-23 Mitralign, Inc. Tissue fastening systems and methods utilizing magnetic guidance
US8182528B2 (en) 2003-12-23 2012-05-22 Sadra Medical, Inc. Locking heart valve anchor
US7311730B2 (en) 2004-02-13 2007-12-25 Shlomo Gabbay Support apparatus and heart valve prosthesis for sutureless implantation
US8206439B2 (en) 2004-02-23 2012-06-26 International Heart Institute Of Montana Foundation Internal prosthesis for reconstruction of cardiac geometry
WO2005087139A1 (fr) 2004-03-15 2005-09-22 Baker Medical Research Institute Traitement d'une defaillance valvulaire
NL1025830C2 (nl) 2004-03-26 2005-02-22 Eric Berreklouw Samenstel omvattende een ring voor bevestiging in een door lichaamsweefsel omgeven doorgang alsmede een applicator voor het in de doorgang plaatsen van de ring.
ES2407684T3 (es) 2004-05-05 2013-06-13 Direct Flow Medical, Inc. Válvula cardiaca sin estent con estructura de soporte formada en el sitio
US20050250985A1 (en) 2004-05-07 2005-11-10 Usgi Medical Inc. Self-locking removable apparatus and methods for manipulating and securing tissue
US8052748B2 (en) 2004-05-14 2011-11-08 St. Jude Medical, Inc. Systems and methods for holding annuloplasty rings
US20050288783A1 (en) 2004-06-29 2005-12-29 Emanuel Shaoulian Methods for treating cardiac valves using magnetic fields
EP1781179A1 (fr) 2004-07-06 2007-05-09 Baker Medical Research Institute Traitement d'insuffisance vasculaire
JP2008506470A (ja) 2004-07-15 2008-03-06 ミカーディア コーポレーション 心臓弁を形成する植え込み片（インプラント）及びその形成方法
JP3714945B1 (ja) 2004-07-27 2005-11-09 シャープ株式会社 金属イオン溶出ユニット及びこれを備えた電気機器
US8012202B2 (en) 2004-07-27 2011-09-06 Alameddine Abdallah K Mitral valve ring for treatment of mitral valve regurgitation
US6951571B1 (en) 2004-09-30 2005-10-04 Rohit Srivastava Valve implanting device
WO2006052687A1 (fr) 2004-11-03 2006-05-18 North Carolina State University Dispositif de fixation et appareil associe
US20080067713A1 (en) 2004-12-14 2008-03-20 Robert Bordener Method of producing and business model for applying a thin laminate sheet of a decorative material
JP2008532573A (ja) 2005-01-21 2008-08-21 ジェン ４，リミティド ライアビリティー カンパニー 二股グラフト及び脚部取付けステント要素を採用したモジュール式ステントグラフト
EP1838247A4 (fr) 2005-01-21 2009-06-10 Innovia Llc Valvule-stent et catheter de deploiement associe
US20110060407A1 (en) 2005-02-07 2011-03-10 Ted Ketai Methods, systems and devices for cardiac valve repair
US20100298929A1 (en) 2005-02-07 2010-11-25 Thornton Troy L Methods, systems and devices for cardiac valve repair
AU2006212750B2 (en) 2005-02-07 2011-11-17 Evalve, Inc. Methods, systems and devices for cardiac valve repair
US20060206203A1 (en) 2005-03-10 2006-09-14 Jun Yang Valvular support prosthesis
WO2006097931A2 (fr) 2005-03-17 2006-09-21 Valtech Cardio, Ltd. Techniques de traitement de la valve mitrale
EP2767260B1 (fr) 2005-03-25 2019-07-03 St. Jude Medical, Cardiology Division, Inc. Appareil de régulation de la circonférence interne d'un orifice ou d'une lumière anatomique
US8864823B2 (en) 2005-03-25 2014-10-21 StJude Medical, Cardiology Division, Inc. Methods and apparatus for controlling the internal circumference of an anatomic orifice or lumen
US20060241746A1 (en) 2005-04-21 2006-10-26 Emanuel Shaoulian Magnetic implants and methods for reshaping tissue
US7357815B2 (en) 2005-04-21 2008-04-15 Micardia Corporation Dynamically adjustable implants and methods for reshaping tissue
JP5174656B2 (ja) 2005-04-21 2013-04-03 マサチューセッツ インスティテュート オブ テクノロジー 同系または非同系の細胞、組織または器官を含む、外因性免疫原および内因性免疫原に対する免疫応答を改変するための材料および方法
US8333777B2 (en) 2005-04-22 2012-12-18 Benvenue Medical, Inc. Catheter-based tissue remodeling devices and methods
CA2606101A1 (fr) 2005-04-25 2006-11-02 Evalve, Inc. Dispositif et procedes d'annuloplastie endoscopique
US8267993B2 (en) 2005-06-09 2012-09-18 Coroneo, Inc. Expandable annuloplasty ring and associated ring holder
US7286057B2 (en) 2005-06-20 2007-10-23 Biovigil Llc Hand cleanliness
EP1919397B1 (fr) 2005-07-13 2013-01-02 Medtronic, Inc. Valves cardiaques prothetiques percutanees presentant deux parties
US7927371B2 (en) 2005-07-15 2011-04-19 The Cleveland Clinic Foundation Apparatus and method for reducing cardiac valve regurgitation
US20070027533A1 (en) 2005-07-28 2007-02-01 Medtronic Vascular, Inc. Cardiac valve annulus restraining device
US7611534B2 (en) 2005-08-25 2009-11-03 The Cleveland Clinic Foundation Percutaneous atrioventricular valve and method of use
US9492277B2 (en) 2005-08-30 2016-11-15 Mayo Foundation For Medical Education And Research Soft body tissue remodeling methods and apparatus
US20070055368A1 (en) 2005-09-07 2007-03-08 Richard Rhee Slotted annuloplasty ring
JP4958907B2 (ja) 2005-09-07 2012-06-20 メドテンチア インターナショナル エルティーディ オーワイ 心臓弁の機能を改善するための機器および方法
US7695510B2 (en) 2005-10-11 2010-04-13 Medtronic Vascular, Inc. Annuloplasty device having shape-adjusting tension filaments
US8092525B2 (en) 2005-10-26 2012-01-10 Cardiosolutions, Inc. Heart valve implant
US20070112423A1 (en) 2005-11-16 2007-05-17 Chu Jack F Devices and methods for treatment of venous valve insufficiency
US20070142907A1 (en) 2005-12-16 2007-06-21 Micardia Corporation Adjustable prosthetic valve implant
US7637946B2 (en) 2006-02-09 2009-12-29 Edwards Lifesciences Corporation Coiled implant for mitral valve repair
US7431692B2 (en) 2006-03-09 2008-10-07 Edwards Lifesciences Corporation Apparatus, system, and method for applying and adjusting a tensioning element to a hollow body organ
JP5198431B2 (ja) 2006-04-12 2013-05-15 メドトロニック ヴァスキュラー インコーポレイテッド 螺旋アンカを有する弁形成装置
US20070244555A1 (en) 2006-04-12 2007-10-18 Medtronic Vascular, Inc. Annuloplasty Device Having a Helical Anchor and Methods for its Use
US8551161B2 (en) 2006-04-25 2013-10-08 Medtronic Vascular, Inc. Cardiac valve annulus restraining device
WO2007130881A2 (fr) 2006-04-29 2007-11-15 Arbor Surgical Technologies, Inc. Ensembles de valves cardiaques prosthétiques à composants multiples et appareil et procédés pour leur implantation
US9101338B2 (en) 2006-05-03 2015-08-11 Mayo Foundation For Medical Education And Research Soft body tissue remodeling methods and apparatus
US20070276478A1 (en) 2006-05-12 2007-11-29 Micardia Corporation Intraoperative and post-operative adjustment of an annuloplasty ring
US20090088838A1 (en) 2006-05-12 2009-04-02 Shaolian Samuel M Adjustable annuloplasty ring and activation system
US20070293942A1 (en) 2006-06-16 2007-12-20 Daryush Mirzaee Prosthetic valve and deployment method
US7799073B2 (en) 2006-07-12 2010-09-21 Tigran Khalapyan Annuloplasty system and surgical method
WO2008015257A2 (fr) 2006-08-02 2008-02-07 Syntach Ag Implant luminal avec grand rapport d'expansion
US8430926B2 (en) 2006-08-11 2013-04-30 Japd Consulting Inc. Annuloplasty with enhanced anchoring to the annulus based on tissue healing
EP2068768A4 (fr) 2006-09-25 2014-01-08 Corassist Cardiovascular Ltd Procédé et système permettant d'améliorer la fonction diastolique du coeur
WO2008060553A1 (fr) 2006-11-14 2008-05-22 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Annuloplastie de valve mitrale réalisée par transcathéter dans le sinus coronaire et dispositif de protection de l'artère coronaire et du myocarde
US9974653B2 (en) 2006-12-05 2018-05-22 Valtech Cardio, Ltd. Implantation of repair devices in the heart
JP2010511469A (ja) * 2006-12-05 2010-04-15 バルテック カーディオ，リミティド セグメント化リング配置
US9226648B2 (en) * 2006-12-21 2016-01-05 Intuitive Surgical Operations, Inc. Off-axis visualization systems
US9107750B2 (en) 2007-01-03 2015-08-18 St. Jude Medical, Cardiology Division, Inc. Implantable devices for controlling the size and shape of an anatomical structure or lumen
US20100121433A1 (en) 2007-01-08 2010-05-13 Millipede Llc, A Corporation Of Michigan Reconfiguring heart features
US9192471B2 (en) 2007-01-08 2015-11-24 Millipede, Inc. Device for translumenal reshaping of a mitral valve annulus
US20100249920A1 (en) 2007-01-08 2010-09-30 Millipede Llc Reconfiguring heart features
US20080177380A1 (en) 2007-01-19 2008-07-24 Starksen Niel F Methods and devices for heart tissue repair
WO2008091614A1 (fr) 2007-01-23 2008-07-31 Cvdevices, Llc Systèmes et procédés de remodelage d'anneau de valvule
WO2008097999A2 (fr) 2007-02-05 2008-08-14 Mitralsolutions, Inc. Système peu invasif pour distribuer et fixer un implant annulaire
WO2008098226A1 (fr) 2007-02-09 2008-08-14 Edwards Lifesciences Corporation Anneaux pour annuloplastie taillés progressivement
EP2129333B1 (fr) 2007-02-16 2019-04-03 Medtronic, Inc Valvules cardiaques artificielles de remplacement
US20080228265A1 (en) 2007-03-13 2008-09-18 Mitralign, Inc. Tissue anchors, systems and methods, and devices
US9138315B2 (en) 2007-04-13 2015-09-22 Jenavalve Technology Gmbh Medical device for treating a heart valve insufficiency or stenosis
US8036702B2 (en) 2007-05-14 2011-10-11 Intel Corporation Method and apparatus for multicarrier communication in wireless systems
US9566178B2 (en) * 2010-06-24 2017-02-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9848981B2 (en) 2007-10-12 2017-12-26 Mayo Foundation For Medical Education And Research Expandable valve prosthesis with sealing mechanism
US8157852B2 (en) 2008-01-24 2012-04-17 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
EP3572044B1 (fr) 2008-01-24 2021-07-28 Medtronic, Inc. Stents pour des valvules cardiaques prothétiques
US7993395B2 (en) 2008-01-25 2011-08-09 Medtronic, Inc. Set of annuloplasty devices with varying anterior-posterior ratios and related methods
DE102008013858A1 (de) * 2008-03-12 2009-09-24 Siemens Aktiengesellschaft Kathetervorrichtung und zugehörige medizinische Untersuchungs- und Behandlungseinrichtung
US20090248148A1 (en) 2008-03-25 2009-10-01 Ellipse Technologies, Inc. Systems and methods for adjusting an annuloplasty ring with an integrated magnetic drive
WO2009126629A1 (fr) 2008-04-09 2009-10-15 Georgia Tech Research Corporation Anneaux d'annuloplastie et procédés de réparation de valvule cardiaque
US8795352B2 (en) 2008-04-15 2014-08-05 Medtronic Vascular, Inc. Devices and methods for treating valvular regurgitation
US20090276040A1 (en) 2008-05-01 2009-11-05 Edwards Lifesciences Corporation Device and method for replacing mitral valve
US20090287304A1 (en) 2008-05-13 2009-11-19 Kardium Inc. Medical Device for Constricting Tissue or a Bodily Orifice, for example a mitral valve
US9192472B2 (en) * 2008-06-16 2015-11-24 Valtec Cardio, Ltd. Annuloplasty devices and methods of delivery therefor
EP3878408A1 (fr) 2008-07-21 2021-09-15 Jenesis Surgical, LLC Appareil de support endoluminal
BRPI0916696A2 (pt) 2008-07-29 2015-11-17 St Jude Medical Cardiology Div método e sistema para ajuste a longo prazo de um dispositivo de implante
EP2358308B1 (fr) 2008-09-15 2019-11-27 Medtronic, Inc. Outils de remodelage de tissu
US8287591B2 (en) 2008-09-19 2012-10-16 Edwards Lifesciences Corporation Transformable annuloplasty ring configured to receive a percutaneous prosthetic heart valve implantation
US8906046B2 (en) 2008-09-20 2014-12-09 Microkoll Inc. Apparatus and method for tissue adhesion
WO2010048151A1 (fr) 2008-10-20 2010-04-29 Mitralsolutions, Inc. Procédé de réglage post-opératoire d'un implant de valvule mitrale
US20100152838A1 (en) 2008-12-15 2010-06-17 Wei-Chang Kang Implantable Valvular Prosthesis
USD627245S1 (en) 2008-12-15 2010-11-16 Garmin Switzerland Gmbh Friction mount
US9011530B2 (en) 2008-12-22 2015-04-21 Valtech Cardio, Ltd. Partially-adjustable annuloplasty structure
US8926696B2 (en) 2008-12-22 2015-01-06 Valtech Cardio, Ltd. Adjustable annuloplasty devices and adjustment mechanisms therefor
US8715342B2 (en) 2009-05-07 2014-05-06 Valtech Cardio, Ltd. Annuloplasty ring with intra-ring anchoring
US8545553B2 (en) 2009-05-04 2013-10-01 Valtech Cardio, Ltd. Over-wire rotation tool
WO2010082187A1 (fr) 2009-01-16 2010-07-22 Novate Medical Limited Dispositif de filtre vasculaire
AU2010206732A1 (en) 2009-01-22 2011-08-25 St. Jude Medical, Cardiology Division, Inc. Post-operative adjustment tool, minimally invasive attachment apparatus, and adjustable tricuspid ring
BRPI1007767A2 (pt) 2009-02-09 2017-06-27 St Jude Medical Cardiology Div Inc dispositivo de colocação, e, aparelho de afixação reversível
AU2010226495A1 (en) * 2009-03-19 2011-09-29 Millipede Llc Reconfiguring heart features
US9980818B2 (en) 2009-03-31 2018-05-29 Edwards Lifesciences Corporation Prosthetic heart valve system with positioning markers
EP2419050B2 (fr) 2009-04-15 2023-10-18 Edwards Lifesciences CardiAQ LLC Implant vasculaire et système d'introduction
US9730790B2 (en) 2009-09-29 2017-08-15 Edwards Lifesciences Cardiaq Llc Replacement valve and method
EP2482749B1 (fr) 2009-10-01 2017-08-30 Kardium Inc. Kit de construction de tissu ou d'orifice corporel, par exemple de valvule mitrale
US8277502B2 (en) 2009-10-29 2012-10-02 Valtech Cardio, Ltd. Tissue anchor for annuloplasty device
US8940042B2 (en) 2009-10-29 2015-01-27 Valtech Cardio, Ltd. Apparatus for guide-wire based advancement of a rotation assembly
US9011520B2 (en) 2009-10-29 2015-04-21 Valtech Cardio, Ltd. Tissue anchor for annuloplasty device
US20110230961A1 (en) 2010-01-05 2011-09-22 Micardia Corporation Dynamically adjustable annuloplasty ring and papillary muscle repositioning suture
US10959840B2 (en) 2010-01-20 2021-03-30 Micro Interventional Devices, Inc. Systems and methods for affixing a prosthesis to tissue
US9107749B2 (en) 2010-02-03 2015-08-18 Edwards Lifesciences Corporation Methods for treating a heart
US9504572B2 (en) 2010-02-17 2016-11-29 Medtronic Vascular, Inc. Apparatus and methods for creating a venous valve from autologous tissue
US20110224785A1 (en) 2010-03-10 2011-09-15 Hacohen Gil Prosthetic mitral valve with tissue anchors
US8357195B2 (en) 2010-04-15 2013-01-22 Medtronic, Inc. Catheter based annuloplasty system and method
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
US8992604B2 (en) 2010-07-21 2015-03-31 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
US20120053680A1 (en) 2010-08-24 2012-03-01 Bolling Steven F Reconfiguring Heart Features
GB201017921D0 (en) * 2010-10-22 2010-12-01 Ucl Business Plc Prothesis delivery system
US9044221B2 (en) * 2010-12-29 2015-06-02 Neochord, Inc. Exchangeable system for minimally invasive beating heart repair of heart valve leaflets
US8845717B2 (en) * 2011-01-28 2014-09-30 Middle Park Medical, Inc. Coaptation enhancement implant, system, and method
ES2568627T3 (es) 2011-01-31 2016-05-03 St. Jude Medical, Inc. Conjunto de ajuste para un dispositivo de válvula protésica ajustable
US9402721B2 (en) * 2011-06-01 2016-08-02 Valcare, Inc. Percutaneous transcatheter repair of heart valves via trans-apical access
US9918840B2 (en) 2011-06-23 2018-03-20 Valtech Cardio, Ltd. Closed band for percutaneous annuloplasty
US9364326B2 (en) 2011-06-29 2016-06-14 Mitralix Ltd. Heart valve repair devices and methods
US9827093B2 (en) 2011-10-21 2017-11-28 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US8858623B2 (en) 2011-11-04 2014-10-14 Valtech Cardio, Ltd. Implant having multiple rotational assemblies
EP2886084B1 (fr) * 2011-12-12 2018-02-14 David Alon Dispositif de réparation de valvule cardiaque
US9078747B2 (en) * 2011-12-21 2015-07-14 Edwards Lifesciences Corporation Anchoring device for replacing or repairing a heart valve
EP3542758B1 (fr) 2012-02-29 2022-12-14 Valcare, Inc. Système d'annuloplastie percutanée à réglage antérieur-postérieur
US9168122B2 (en) 2012-04-26 2015-10-27 Rex Medical, L.P. Vascular device and method for valve leaflet apposition
WO2014043527A2 (fr) 2012-09-14 2014-03-20 Millepede, Llc. Prothèses d'inversion de valvule mitrale
US10849755B2 (en) 2012-09-14 2020-12-01 Boston Scientific Scimed, Inc. Mitral valve inversion prostheses
US10543088B2 (en) 2012-09-14 2020-01-28 Boston Scientific Scimed, Inc. Mitral valve inversion prostheses
NL2009518C2 (nl) 2012-09-26 2014-03-27 Eric Berreklouw Vernauwer voor het sluiten of vernauwen van een doorgang door weefsel van een hol orgaan.
US20140128726A1 (en) * 2012-11-05 2014-05-08 Medtronic, Inc. Alignment of Imaging Modalities
US9439763B2 (en) 2013-02-04 2016-09-13 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
US20160008130A1 (en) 2013-02-28 2016-01-14 Mor Research Applications Ltd. Adjustable annuloplasty apparatus
DK2967834T3 (da) 2013-03-13 2021-04-06 Jenesis Surgical Llc Leddelte kommissurklapstents
WO2014160330A1 (fr) 2013-03-14 2014-10-02 Millepede, Llc. Systèmes et procédés pour remodeler une valvule cardiaque
US20140277427A1 (en) 2013-03-14 2014-09-18 Cardiaq Valve Technologies, Inc. Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
EP3597150A1 (fr) 2013-06-06 2020-01-22 David Alon Réparation et remplacement de valvule cardiaque
US9622863B2 (en) 2013-11-22 2017-04-18 Edwards Lifesciences Corporation Aortic insufficiency repair device and method
US9180005B1 (en) 2014-07-17 2015-11-10 Millipede, Inc. Adjustable endolumenal mitral valve ring
JP6651504B2 (ja) * 2014-08-21 2020-02-19 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． 閉塞を横断するためのデバイス及び方法
WO2016130991A1 (fr) 2015-02-13 2016-08-18 Millipede, Inc. Remplacement de valvule à l'aide d'ancrages rotatifs
US10335275B2 (en) 2015-09-29 2019-07-02 Millipede, Inc. Methods for delivery of heart valve devices using intravascular ultrasound imaging
CN108289737B (zh) 2015-11-17 2020-03-31 魅尔皮德股份有限公司 用于使心脏瓣环重新定形的可植入装置和输送系统
EP3579789A4 (fr) 2017-02-10 2020-09-30 Millipede, Inc. Dispositif implantable et système de mise en place permettant de remodeler un anneau de valvule cardiaque

Also Published As

Publication number Publication date
US10555813B2 (en) 2020-02-11
CN108289737A (zh) 2018-07-17
US20170135816A1 (en) 2017-05-18
WO2017087424A1 (fr) 2017-05-26
JP6892446B2 (ja) 2021-06-23
IL259333A (en) 2018-07-31
CN111329541B (zh) 2023-09-19
US11576778B2 (en) 2023-02-14
CN111329541A (zh) 2020-06-26
US20190374343A1 (en) 2019-12-12
CN108289737B (zh) 2020-03-31
US20230157823A1 (en) 2023-05-25
JP2018533446A (ja) 2018-11-15
EP3377000A1 (fr) 2018-09-26
JP2021121364A (ja) 2021-08-26

Similar Documents

Publication Publication Date Title
US11576778B2 (en) Implantable device and delivery system for reshaping a heart valve annulus
US11432927B2 (en) Implantable device and delivery system for reshaping a heart valve annulus
US11241309B2 (en) Methods for delivery of heart valve devices using intravascular ultrasound imaging
CN110678148B (zh) 用于假体心脏瓣膜装置的具有系绳的递送系统及相关联的方法
US10463481B2 (en) Prosthetic valve for replacing mitral valve
EP3806779B1 (fr) Dispositif de remplacement de feuillet de valvule cardiaque et système de pose de valvule cardiaque à plusieurs étages et à plusieurs lumières
EP3256076B1 (fr) Dispositifs d'accrochage de valvule cardiaque

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180518

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BOSTON SCIENTIFIC SCIMED, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20200603

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20220301

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTC Intention to grant announced (deleted)
INTG Intention to grant announced

Effective date: 20220722

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: AT

Ref legal event code: REF

Ref document number: 1546743

Country of ref document: AT

Kind code of ref document: T

Effective date: 20230215

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602016077709

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1546743

Country of ref document: AT

Kind code of ref document: T

Effective date: 20230201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230201

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230601

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230501

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230201

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230201

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230201

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230201

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230201

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230201

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230601

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230502

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230201

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230201

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230201

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230201

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230201

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602016077709

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230201

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20231020

Year of fee payment: 8

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20231103

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20231019

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230201

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20231019

Year of fee payment: 8

Ref country code: DE

Payment date: 20231019

Year of fee payment: 8